[go: up one dir, main page]

US20050149150A1 - System and method for the photodynamic treatment of burns, wounds, and related skin disorders - Google Patents

System and method for the photodynamic treatment of burns, wounds, and related skin disorders Download PDF

Info

Publication number
US20050149150A1
US20050149150A1 US10/903,483 US90348304A US2005149150A1 US 20050149150 A1 US20050149150 A1 US 20050149150A1 US 90348304 A US90348304 A US 90348304A US 2005149150 A1 US2005149150 A1 US 2005149150A1
Authority
US
United States
Prior art keywords
skin
aging
collagen
light
mmp
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US10/903,483
Other languages
English (en)
Inventor
David McDaniel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GENTLE WAVES LLC
Original Assignee
Light BioScience LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Light BioScience LLC filed Critical Light BioScience LLC
Priority to US10/903,483 priority Critical patent/US20050149150A1/en
Assigned to LIGHT BIOSCIENCE, LLC reassignment LIGHT BIOSCIENCE, LLC ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: MCDANIEL, DAVID H.
Publication of US20050149150A1 publication Critical patent/US20050149150A1/en
Assigned to GENTLEWAVES LLC reassignment GENTLEWAVES LLC ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: LIGHT BIOSCIENCE LLC
Priority to US12/550,464 priority patent/US9144690B2/en
Assigned to GENTLEWAVES LIMITED reassignment GENTLEWAVES LIMITED ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: GENTLE WAVES LLC
Assigned to GENTLE WAVES LLC reassignment GENTLE WAVES LLC ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: GENTLEWAVES LIMITED
Priority to US14/807,653 priority patent/US20150328479A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N5/0613—Apparatus adapted for a specific treatment
    • A61N5/0616—Skin treatment other than tanning
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N2005/065—Light sources therefor
    • A61N2005/0651—Diodes
    • A61N2005/0652—Arrays of diodes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N2005/0658—Radiation therapy using light characterised by the wavelength of light used
    • A61N2005/0659—Radiation therapy using light characterised by the wavelength of light used infrared
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N2005/0658—Radiation therapy using light characterised by the wavelength of light used
    • A61N2005/0662—Visible light
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N2005/0658—Radiation therapy using light characterised by the wavelength of light used
    • A61N2005/0662—Visible light
    • A61N2005/0663—Coloured light
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N2005/0664—Details
    • A61N2005/0667—Filters

Definitions

  • This invention relates to method and devices for the photodynamic regulation of cell proliferation and gene expression.
  • the invention relates to the reducing, reversing, and/or diminishing the effects of sunburn, thermal burns, chemical burns, radiation burns, various types of wounds, such as traumatic, surgical, laser, chemical peel, cosmetic surgery, warfare agents or injuries, freezing, hypoxia, vascular insufficiency, bruising, chronic ulcers, etc., allergic reactions or contact dermatitis, and various inflammatory diseases.
  • Chronological aging i.e., the aging of skin caused by exposure to natural and synthetic light sources, disease, and trauma all bring about changes in the appearance of human and mammalian skin as well as changes in the structure and function of the skin. All living cells, tissues and organs also undergo changes associated with chronological aging, bruising, photoaging, disease, and trauma. Since the human skin is an organ that is highly visible, the changes associated with these conditions are readily apparent and visible. These changes are reflections of the underlying structural and functional changes.
  • UVA ultraviolet A
  • UVB ultraviolet B
  • UV radiation is composed of ultraviolet (UV), visible and infrared, light.
  • Current conventions divide UV radiation into UVA (320-400 nm), UVB (290-320 nm) and UVC ( ⁇ 290 nm).
  • UVC radiation is blocked by ozone in the stratosphere and does not reach the earth's surface, but can be generated by germicidal lamps and other machinery.
  • UVA and UVB sunlight do reach the earth and are believed to be the principal agents of photoaging.
  • UVA radiation is further subdivided into UVA 1 and UVA 2. While UVB has been believed to be the primary agent for photoaging, it is now appreciated that certain wavelength ranges within the UVA rays also contribute to changes associated with photoaging.
  • Acute environmental injuries include sunburn from UV light and other thermal, chemical, and other types of burns or burn-like injuries. These type of injuries produce not only damaged cells, but dying cells. Damaged cells may either repair the damage and return to normal, repair the damage imperfectly and produce an abnormal or sub-optimally functioning cell, or the cells may die. In the case of sunburn chronic sun-damage accumulates damaged and imperfectly repaired cells to produce what might be termed ‘solar scars’ but we more commonly think of these as ‘wrinkles’. That is a wrinkle is really the result of accumulation of imperfectly repaired cell damage. Likewise the brown ‘liver’ or ‘age spots’ that are common as one ages and photoages are similarly damage to the pigment cells or melanocytes.
  • Acute UV injury or sunburn produces dying cells in the upper skin layer or epidermis called ‘sunburn cells’.
  • Counting sunburn cells is a classic scientific method to quantify the severity of damage to these keratinocyte cells.
  • Therapies which reduce the number of sunburn cells are considered beneficial to diminishing the severity of the injury or repairing or reversing the injury. More generally speaking damaged cells which might recover or die are termed ‘apoptotic’ cells and those cells which are irreversibly damaged and will die are termed ‘necrotic’ cells.
  • Treatments which can turn necrotic cells into living cells would be considered treatments which ‘rescue’ or ‘revive’ the cells which are destined for death.
  • Such treatments and therapies would have great importance in treating not only acute sunburn, but sub-acute sun damage that leads to accumulated chronic damage.
  • the ability to ‘rescue’ dying cells in wounds, burns, etc would have a powerful impact on healing time, scarring or lack thereof, infection risk, and even survival of entire organs or organisms.
  • the pertinent arts have, heretofore, been unable to produce a system or method for reviving or rescuing necrotic cells or those in advanced stages of necrosis.
  • UVA and UVB light exposure to human skin triggers a series of molecular events including the induction of reactive oxygen species (ROS) in the skin.
  • ROS reactive oxygen species
  • the skin's reaction to UVA or UVB (or combined) wounding is to repair the wound through the skins wound healing mechanism.
  • these wound repair mechanisms are imperfect which is considered by many to be a solar scar.
  • chronic solar scarring develops which manifests itself in the visible phenotypic changes termed photoaging, which might also be considered the visible outward evidence of solar scars.
  • Photoaging of the skin may occur through acute injury at higher levels, such as what one associates with sunburn. This triggers an inflammatory process in the skin and the associated cellular mechanisms. There is also a more chronic low-level type of injury that does not produce a sunburn reaction, but which produces the changes of chronic photoaging. Other processes, which are known to decrease collagen production and increase collagen-dissolving enzymes, such as tobacco smoking, also are associated with changes that visibly appear, similar to the photoaging from UVA/UVB light. This can be seen strikingly in photographs of identical twins wherein only one twin smoked tobacco for many years.
  • UVB radiation in sufficient doses produces reddening or sun burning of the skin.
  • the threshold level is typically described as minimal erythemal dose (MED), typically produced by 290-300 nm UVB wavelengths. As the wavelengths increase they become much less likely to produce the redness and burning reactions and indeed wavelengths of 320 nm are about 100 times as powerful as wavelengths of 340 nm approximately 100 times less powerful than the 290-300 nm range of producing erythema and sunburns.
  • the total UVB exposure is more related to the appearance of photoaging and sunburns are more likely to trigger malignant changes in the skin such as malignant melanoma.
  • UVA radiation can produce redness, but also produced tanning and these are the wavelengths typically used for the so-called tanning beds.
  • UVA radiation is a longer wavelength and is proportionately greater in the early morning and late afternoon and the UVB rays, which are typically most predominant and intense at the midday summer sun time exposure period, UVA radiation may also penetrate certain sun blocks and certain sunscreens and also window glass on automobiles, thus accounting for the frequently observed greater wrinkling, brown pigmentation and redness and overall aged appearance on the left side of the face than the right in patients who occupationally or recreationally spend considerable time driving a left hand drive motor vehicle.
  • the chronological changes and photoaging changes typically are manifest by fine lines and wrinkling of the skin.
  • the skin is composed of several layers, the outermost layer is called the stratamocornium (SC), next layer is the epidermis (EPI), and underneath the epidermis lies the dermis (DER).
  • SC stratamocornium
  • EPI epidermis
  • DER underneath the epidermis lies the dermis
  • the outer SC serves primarily a barrier function to protect the skin from environmental exposure and also to help minimize water loss from the skin.
  • the epidermis serves many important and diverse roles as does the dermis.
  • the dermis contains the principal structural proteins of the skin. These proteins are collagen, elastin and ground substance. They are manufactured by the fibroblast cells within the dermis. Fi
  • the dermis also contains blood vessels, nerve fibers, oil and sweat glands, hair follicles and many other important components.
  • Fibroblasts produced what are termed pro-collagen fibers, which are then insymmetrically assembled into collagen fibers, and form bundles within the dermis.
  • Other molecules, such as decorin affect the function of the collagen.
  • Collagen I, III, etc. there are various sub-types of collagen fibers such as Collagen I, III, etc., within the body. Collagen I comprises approximately 85% of the skin and Collagen III approximately 10%. However, in photoaged skin the amount of Collagen I decreases so the ratio of Collagen III/I is altered.
  • MMP matrix metalloproteinases
  • Fibroblasts also have important functions in wound healing with the removal of damaged structural ECM and the repair and production of (ECM).
  • ECM structural ECM
  • the Collagen I is degraded principally by MMP 1 (collagenase).
  • MMP enzymes which degrade one or more of the structural proteins in the skin. While these degrading MMP enzymes serve an important role in removing damaged skin (for example, in wound healing), their activation and synthesis in increased quantities in normal skin helps contribute to the changes seen in both chronological and photoaging. Likewise, if the production of Collagen I is decreased or diminished this results in changes which are associated with chronologically or photoaged skin. Aging or senescent fibroblasts may exhibit decreased synthesis of Collagen I and increased synthesis of MMP 1. Similar changes are seen with UVA/UVB exposure. Other environmental agents may produce similar changes.
  • Certain drugs, therapies, chemicals, active agents have been demonstrated to reversing the appearance of or phenotype of a chronologically aging or photoaging skin.
  • Some topically applied agents serve as a physical or optical barrier either by reflection or absorption of ultraviolet light thus protecting the skin.
  • enzymes that have been to shown actually repair the DNA dimers which are produced from UV damage.
  • Other topically applied or oral or systemically agents have been shown to improve the appearance of the skin.
  • One of the classic and well-known agents is a topical Vitamin A derivatives termed Retinoids.
  • Numerous studies have demonstrated the ability to improve the appearance or phenotype of photoaged skin with the use of all-trans retinoic acid (RA). Many of the pathways involve the mechanism of action of RA and also Retinol (RO). Much of the mechanism of action in the cell signaling pathways through which RA appears to produce anti-aging effects.
  • One of the goals of some current anti-aging therapies is to increase production of collagen in the ECM and the dermis of the skin. Some believe collagen I is the more desirable form of collagen to increase. There is some support for this since photoaged skin has less desirable visco elastic properties and this is thought in part to be due to the increased proportion of collagen III to collagen I. Other anti-aging approaches indicates that reducing the activity or production of the degrading enzymes in the ECM will similarly produce an anti-aging effect in the appearance of the skin. Doing a combination of both is even more beneficial. An analogy one might make is the production of new collagen I and that of freshly newly fallen snow. The amount of accumulation of the fresh snowfall is dependent both on the amount of snow that is fallen as well as the amount of the freshly fallen snow which then melts.
  • an anti-aging therapy which stimulated new collagen production (newly fallen snow).
  • new collagen production new collagen production
  • a piece of black asphalt in a parking lot abuts a piece of warmer black asphalt adjoins a colder piece of concrete or frozen ground, while the amount of new snowfall is equal in both areas, the amount of accumulated snow is less was melted by the asphalt.
  • an anti-aging therapy stimulates collagen I production, but does not diminish MMP 1 activity, the net increase in collagen I will be smaller than if the MMP 1 activity is also decreased.
  • Non-ablative methods have typically been thermal in nature and through various means of laser light, intense pulsed light, radio frequency or microwave energy delivery then produced a thermal injury to the dermis.
  • the theory behind these therapies is that this injury will result in a net increase in the desirable structural proteins, while not triggering, worsening, scarring or other complications. Results are occasionally traumatic but have been extremely variable with this therapy. The variability in individuals wound healing repair mechanism and the overall health of their body and skin and many other factors contribute to this variability.
  • the present invention is directed to method and devices for improving the appearance of photoaged or damaged skin.
  • Methods and devices involve the regulation of cell proliferation and gene expression of skin and other cells through photodynamic means such as photomodulation.
  • One embodiment of the invention relates to reducing the undesirable effects and enhancing the beneficial effects of narrowband and wideband multichromatic electromagnetic radiation, as well as monochromatic radiation, emitted by sources including, but not limited to lasers (monochromatic and filtered, narrowband multichromatic), LED's (narrowband multichromatic), radio frequency, electromagnetic therapy or non ablative thermally mediated surgical procedures, etc.
  • sources including, but not limited to lasers (monochromatic and filtered, narrowband multichromatic), LED's (narrowband multichromatic), radio frequency, electromagnetic therapy or non ablative thermally mediated surgical procedures, etc.
  • LED photomodulation and other similar non-LED therapies may be used to enhance the desired effects or inhibit the undesirable one. This may be accomplished via means such as thermal injury to the skin which forces the expression of MMP and causing an increase structural proteins like collagen. LED light sources may also boost collagen while decreasing the upregulated MMP to produce a beneficial net effect. Such means generally quench the inflammatory processes that thermal therapies typically produce.
  • One embodiment of the invention is directed to methods for both inhibiting, as well as reversing the appearance of photoaging (beauty maintenance or skin fitness) or chronological or environmentally damaged induced aging of human skin by application of photomodulation by, for example LED or other electromagnetic radiation treatment.
  • the invention is directed to the regulation of cell proliferation of cells of the skin, and/or the regulation of gene expression in such cells.
  • Another embodiment of the invention is directed to the various genotypes that characterize different phenotypes of aging skin and also a database comprising a collection or library of such phenotypes.
  • the data base may comprise a plurality of genotypes identified from a variety of different individuals with the same disorder, or a variety of individuals with different disorders.
  • Another embodiment of the invention is directed to photomodulation by light or electromagnetic radiation so as to effect cell proliferation and/or gene expression.
  • electromagnetic radiation include ultrasound, radiowaves, micro rays, magnetic fields, any electrical stimulation that produces changes in the genotype or phenotype of aging skin, and combinations thereof.
  • FIG. 1 is a chart which illustrates the RT-PCR expression of MMP-1 in cultured human fibroblasts.
  • FIG. 2 is a chart which illustrates the RT-PCR expression of MMP-1 in cultured human fibroblasts under a variety of light exposure conditions.
  • FIG. 3 is a chart which illustrates the RT-PCR expression of MMP-1 in cultured human fibroblasts at varying energy fluences.
  • FIG. 4 is a chart which illustrates the RT-PCR expression of cytochrome c oxidase 2 in cultured human fibroblasts after exposure to narrowband, multichromatic electromagnetic radiation.
  • FIG. 5 is a chart which illustrates the RT-PCR expression of collagen I in cultured human fibroblasts after exposure to narrowband, multichromatic electromagnetic radiation.
  • FIG. 6 is another chart which illustrates the RT-PCR expression of collagen I in cultured human fibroblasts after exposure to narrowband, multichromatic electromagnetic radiation.
  • FIG. 7 is a chart which illustrates the RT-PCR expression of MMP-1, collagen I, and cytochrome c oxidase 2 in cultured human fibroblasts after exposure to narrowband, multichromatic electromagnetic radiation.
  • FIG. 8 is another chart which illustrates the RT-PCR expression of collagen I in cultured human fibroblasts after exposure to narrowband, multichromatic electromagnetic radiation.
  • FIG. 9 is another chart which illustrates the RT-PCR expression of collagen I in cultured human fibroblasts after exposure to narrowband, multichromatic electromagnetic radiation.
  • FIG. 10 is a chart which illustrates the RT-PCR expression of cytochrome b in cultured human fibroblasts after exposure to narrowband, multichromatic electromagnetic radiation.
  • FIG. 11 is a chart which illustrates the RT-PCR expression of cytochrome b oxidase I in cultured human fibroblasts after exposure to narrowband, multichromatic electromagnetic radiation.
  • FIG. 12 is a chart which illustrates the RT-PCR expression of atpase6 in cultured human fibroblasts after exposure to narrowband, multichromatic electromagnetic radiation.
  • FIG. 13 is a chart which illustrates the RT-PCR expression of cytochrome c oxidase III in cultured human fibroblasts after exposure to narrowband, multichromatic electromagnetic radiation.
  • FIG. 14 is a chart which illustrates the RT-PCR expression of p53 in cultured human fibroblasts after exposure to narrowband, multichromatic electromagnetic radiation.
  • FIG. 15 is a chart which illustrates the RT-PCR expression of MMP-1 in cultured human fibroblasts after exposure to narrowband, multichromatic electromagnetic radiation with varying energy fluence.
  • FIG. 16 is a chart which illustrates the RT-PCR expression of collagen I in cultured human fibroblasts after exposure to narrowband, multichromatic electromagnetic radiation.
  • FIG. 17 is a another chart which illustrates the RT-PCR expression of collagen I in cultured human fibroblasts after exposure to narrowband, multichromatic electromagnetic radiation employing various light cycle regimen and filters.
  • FIG. 18 is a another chart which illustrates the RT-PCR expression of collagen I in cultured human fibroblasts after exposure to narrowband, multichromatic electromagnetic radiation employing various light cycle regimen and filters.
  • FIG. 19 is a another chart which illustrates the RT-PCR expression of MMP-1 in cultured human fibroblasts after exposure to narrowband, multichromatic electromagnetic radiation employing various light cycle regimen and filters.
  • FIG. 20 is a another chart which illustrates the RT-PCR expression of MMP-1 in cultured human fibroblasts after exposure to narrowband, multichromatic electromagnetic radiation employing various light cycle regimen and filters.
  • FIG. 21 is a chart which illustrates the RT-PCR EGF expression in cultured human fibroblasts after exposure to electromagnetic radiation simulator solar radiation.
  • FIG. 22 is a chart which illustrates the RT-PCR expression of collagen I in cultured human fibroblasts after exposure to electromagnetic radiation simulator solar radiation.
  • FIG. 23 is a chart which illustrates the RT-PCR expression of cJun in cultured human fibroblasts after exposure to electromagnetic radiation simulator solar radiation.
  • FIG. 24 is a chart which illustrates the RT-PCR expression of MMP-1 in cultured human fibroblasts after exposure to electromagnetic radiation simulator solar radiation.
  • FIG. 25 ( a ) illustrates the specific extinction coefficients of various cytochromes at various wavelengths.
  • FIG. 25 ( b ) illustrates specific extinction coefficients of the cytochromes of FIG. 25 ( a ) from 700 nm to 1000 nm.
  • FIG. 26 illustrates specific extinction coefficients vs. wavelength.
  • FIG. 27 shows the emission or spectral output of the LED with dominant visible and secondary infrared (IR) peaks and their relative intensity and shape.
  • FIG. 28 shows the same LED emission with a selective infrared filter in place which reduces both the visible and IR output, but alters the relative ratio of visible to IR light as well as altering the shape of the IR spectral output curve.
  • FIG. 29 shows the emission or spectral output of the LED with dominant visible and secondary infrared (IR) peaks and their relative intensity and shape.
  • FIG. 30 shows the same LED emission with a selective infrared filter in place which reduces both the visible and IR output, but alters the relative ratio of visible to IR light as well as altering the shape of the IR spectral output curve.
  • the present invention is directed to method and devices for the regulation of cell proliferation and gene expression and, in particular, the inhibition of photoaging of the skin, and the revival of necrotic cells.
  • the invention is directed toward a system and method for rejuvenating cells in various stages of necrosis.
  • Photoaging of the skin occurs through many mechanisms, including, for example, environmental factors such as tobacco smoke, exposure to the sun, and poor health, to name a few. These events can triggers an inflammatory process in the skin and the associated cellular mechanisms. There is also a more chronic low-level type of injury that does not produce a sunburn reaction, but which produces the changes of chronic photoaging. Chronological aging of the skin and photoaging and other environmentally induced changes share many or in some cases, all of the same pathways as UV induced photoaging of the skin. These pathways involve up and/or down regulation of cell proliferation and also alterations in the level of expression of many different types of genes.
  • one embodiment of the invention is directed to identifying and correlating the phenotypic and genotypic expression characteristics of photoaging and other skin and cell-associated disorders. Once identified, correlated maps can be compiled and collected into a data base to allow for the rapid and efficient identification of similar disorders and conditions for the purpose of tailoring appropriate treatment. Further, once identified, treatment and appropriate intervention and prevention methods can be used to halt or even reverse the appearance and genotypic characteristics of photoaging. Thus, the invention is not directed to artificially hiding or covering up aspects associated with aging, but actually reversing the processes and mechanisms associated with aging-related phenomena.
  • a further embodiment of the invention is directed to applying these same mechanisms and tools to other cells such as stem cells (completely undifferentiated cells) and progenitor cells (partially differentiated cells).
  • stem cells completely undifferentiated cells
  • progenitor cells partially differentiated cells.
  • Methods to modulate cell proliferation and gene expression include exposure to electromagnetic radiation in an amount or dose that is sufficient to stimulate the desired effect (e.g. see U.S. Pat. Nos. 6,398,753, 5,837,224, and 6,130,254; and U.S. patent application Nos. 2002/0028185, 2001/0053347, 2003/0004556, 2003/0004499, and 2002/0123746, all of which are specifically and entirely incorporated by reference).
  • exposure of skin to LED can stimulate or inhibit the expression of various gene products.
  • photomodulation can be used in combination with certain oral agents (for systemic affects) or topical agents (for localized affects) (e.g. vitamin A, retin A, retinol), for a desired effect unachievable with either stimulant used individually.
  • certain oral agents for systemic affects
  • topical agents for localized affects
  • e.g. vitamin A, retin A, retinol e.g. vitamin A, retin A, retinol
  • the types of cells that can be affected include, but are not limited to skin cells (reversal of photoaging), nerve cells (disease prevention and treatment), stem cells (tissue reconstruction), cells of hair follicles (hair growth or inhibition), cells of the immune system including cells intimately involved with the process of inflammation (due to disease, infection, or congenital disorder), wound repair, and combinations thereof.
  • Modulation can be achieved by exposing cells to electromagnetic radiation (e.g. photomodulation) such as, preferably, visible light, (e.g. purple, blue, green, yellow, orange, red), infrared radiation, ultraviolet light (UVA, UVB, UVA1, UVA2, or combinations thereof), or combinations of any.
  • electromagnetic radiation e.g. photomodulation
  • visible light e.g. purple, blue, green, yellow, orange, red
  • infrared radiation ultraviolet light
  • Preferred exposure strengths and exposure times are as set forth in the attachments hereto, but may include pulsed exposure
  • Ultraviolet light injury triggers reactive oxygen species and a series of cell signaling events called kinase cascades.
  • One of the final common pathway in the up and down regulation of fibroblast activity is through AP-1 which up regulates and increases the production of various MMP's including MMP 1 (collagenase 1 or interstitial collagenase synthesis), MMP 9 (gelatinases B) and MMP 3 (stromelysins 1).
  • MMP 1 collagenase 1 or interstitial collagenase synthesis
  • MMP 9 gelatinases B
  • MMP 3 stromelysins 1).
  • the production of these MMP enzymes results in the breakdown of collagen, elastin and ECM in the dermis of the skin. Simultaneously the actual production of collagen I and other structural proteins may be diminished or down regulated thus further accelerating the process.
  • the aging of living cells, tissues and organs may be related to free radical exposure and oxidative stress.
  • chronological aging results from a decrease antioxidant defense mechanisms while UV photoaging and other environmental stresses can be thought of as increasing oxidative stress.
  • the net result of decreased antioxidant defense or increased oxidative stress is increase production of (ROS) or free radicals.
  • SNPs Single nucleotide polymorphisms
  • characterization of SNPs may allow prediction of whether a patient is more or less likely to develop a specific disease or tumor and thus take known preventative measures.
  • Another possible application is the use of SNPs to screen individuals before placing them on a prescription drug to identify those individuals who might be more likely to develop serious side effects and thus avoid the use of that drug.
  • Another potential novel use of SNPs is to identify the haplotype or patterns of SNPs, which are associate with, for example, chronological aging of the skin. Some individuals and families have reduced risk of skin cancers or simply look younger than their peers of the same age group and like backgrounds.
  • a profile of SNPs can be developed that characterizes common factors associated with the phenotypic changes of aging skin (defined the SNP genotypic pattern that puts an individual at a greater risk of accelerate aging from increased oxidative stress from environmental agents). This allows for a treatment plan, which would have greater anti-aging benefits.
  • TGF-B is a major cytokine for cell signaling and inhibits the growth of epidermal keratinocytes and stimulates the growth of thermal fibroblasts. It also induces synthesis and secretion of the major collagen elastin and inhibits the expression of MMP 1 and MMP 3.
  • TGF-B's TGF-B 1, TBR I, TBR II, many of which are down regulated in aging skin cells.
  • TGF-B is also activity altered in aging skin by binding with Decerin and when this combines with collagen affects the tinsel strength of skin as well as controlling the rate of collagen fiber formation.
  • c Jun MRNA is doubled in activity and age human skin compared to young skin but c-fos was unchanged.
  • MMP 2 is not regulated through AP 1.
  • ERK activity is reduced in aging skin, but JNK activity is increased 3-4 times in aging skin.
  • Environmental insults-damage can vary anatomically over a person's body.
  • Increased MMP's result in reduced levels of ERK, cyclin D2 and type I and III pro collagen. This is part of the core genotype, phenotype stimulating a number of keratinocytes as well as decreasing c-gen activity and increasing ERK activity.
  • Mitochondria and ATP production mechanisms can be modulated by electromagnetic radiation.
  • LED light activates cell surface receptors via redox mediated in activation or a receptor type protein tyrosine phosphatase (RTPT).
  • SAP stress activated pathways
  • mitogen activated pathways compare and contrast SAP increase MMP and decreases pro collagen 1 and 2 if c Jun goes up.
  • MAP stress activated pathways
  • mitogen activated pathways compare and contrast SAP increase MMP and decreases pro collagen 1 and 2 if c Jun goes up.
  • the MAP pathways activate ERK induced cyclins and promote cell growth so that PSAT's tend to increase or decrease protein production whereas the MAPS increase or decrease cell growth.
  • Ras/MAP/AP-1 pathway plays a key role in response to wounding.
  • FGFR1 contains sites in the promoter region and IL1 antagonist promoter.
  • Antioxidant compounds also have anti-erythema sunscreen effect although they may not inhibit the increased MMP after UV exposure, lycopene is one of these.
  • LED photomodulation can also be used to diminish sunburn activity and MMP levels were maxed about 24 hours later.
  • Use a solar simulator to cause a one MED minimal erythema dose on the arm in two places on volunteers and treat one a couple times a day with the GW device and to reduce redness with the chromometer. Biopsy will show what happens when you treat them with GW after UV. Inhibiting cytocrome P-450 breakdown of retinoids increases retinoid strength concentration.
  • the invention includes the surprising discovery that multiple receptor-mediated pathways may be photomodulated in human or mammalian skin that lead to an expression of the genotype associated with a younger or more youthful or less aged skin both in appearance and structurally and functionally.
  • infrared-a radiation induced MMP 1 is capable of producing MMP 1 by way of up regulation or activation of MAPK signaling pathway that is the activation of ERK 1/2 that the promoter region of the MMP 1 gene was activated by IRA without the production of heat, but that TIMP 1 was not increased.
  • MMP-8 or elastase is increased with inflammatory reaction, which also involves AP 1. And when NF-KB is increased it activates more of IL-1 and TNFa that discontinues the presence of continued inflammation.
  • Fibroblasts sensor matrix surround them and when in contact with a matrix they tend to be less active produce little collagen, but when the presence of collagen breaks down products such as gelatin, they tend to produce more collagen if the inflammation persists. The collagen not only proliferates, but produces less scarring.
  • Topical compounds that inhibit cytokines are indirect MMP inhibitors because if they block the pathway the signals MMP the essentially block this. The same is true for MMP regulation.
  • Vitamin C can be topically applied to assemble stable collagen molecules. Collagen I and collagen III can be stimulated by topical of Vitamin C, whereas elastin, Fibrilin 1/2 are not affected nor is MMP 1, 2, and 9 affected. TIMP was increased, TIMP 2 was unchanged.
  • Proteolytic degradation of ECM is an essential feature of repair and remodeling during continuous wound healing.
  • Wound repair consists of narcotic or damaged tissue, cell and/or tissue migration, angiogenisis, remodeling of newly synthesized ECM, and cell growth factor regulations.
  • MMP 1 and MMP 3 increase as well as MMP 2 and 9.
  • MMP 13 in particular, for chronic wounds, but also acute.
  • TIMP is also altered.
  • MMP 1, 3, 9 are increased with UVB; increased elastin and fibrilian verscian; result in the formation of non functional elastin fibers and reduce skin elasticity and aging or photoaged skin.
  • Collagen I is reduced, and UVA shows increased expression of MMP 1, 2, 3.
  • single or multiple light sources may be used, to produce either a single dominant emissive wavelength, i.e., a narrowband multichromatic radiation, or multiple wavelengths (either monochromatic, narrowband multichromatic, wideband multichromatic, or combinations thereof).
  • the single or multiple combinations may be applied either simultaneously or sequentially.
  • a special IR filter may also be added to reduce the IR component of the radiation that the target skin or tissue is exposed to, as this is believed to unsymmetrically dampen the shape of the IR/850 curve.
  • Treatment examples of such a device are shown in the attached drawing figures and illustrate that at 850 nm, there is believed to be a ‘dose dependent’ effect on fibroblasts.
  • the ratio of yellow light to IR radiation in the radiation used for treatment has been found to have an effect on the overall performance of the present system. Relative amounts of each type of radiation are believed to be important, more so than the actual radiation level (provided that ablation does not occur). At about 4 mW/cm 2 for 590 nm and about 1 mW/cm 2 for the 850 nm (i.e., a 4:1 ratio of yellow to IR) has been found to produce good results. Another factor to consider is the shape of the amplitude vs. wavelength curve for the IR component of the system.
  • the ‘code’ refers to the pulse scheme for various treatment regimen. This includes various factors such as pulse length, interpulse delay, and pulse repetition.
  • a treatment may comprise a pulse code of 250 msec “on” time, 100 msec “off” time (or dark period), and 100 pulses. This produces a total energy fluence, in J/cm2, of 25 seconds times the power output level of the emitters.
  • the present invention is also related to a method and apparatus for treating sunburn and other sun-related photoeffects on human or mammalian skin.
  • One approach is to use Retin A for prior to sun exposure and research is being conducted using vitamins C, E, and other antioxidants topically.
  • Another approach being tried is the use of the antioxidant Lycopene, administered orally, to quench some of inflammation from sunburn.
  • the present invention shows great improvement of such treatment methods, however.
  • the solar simulator of the present invention is, in some ways, a model for other wound healings.
  • the present invention employs a treatment that simulates sunlight broken down into its component parts.
  • the UVA1 portion is used in some embodiments, but there is UVB and combinations of UVA and UVB that are more oncogenic.
  • UV, and in particular UVA1 causes skin sagging and photoaging, changes to the dermal matrix and structural proteins, and upregulates MMPs.
  • UV radiation also causes the upregulation of inflammatory pathways such as IL1, IL6 and NFKB. These pathways are known to affect aging and other sun-related skin disorders and environmental damage, such as smoking, pollution, drugs, diseases, thermal injuries, other wounds.
  • the present invention is believed to inhibit or reverse the effects of photoaging and other skin disorders by reversing the direction of gene up/down regulation from the unfavorable and destructive directions caused by the effects of the solar simulator UVA1 for things like collagen, MMP1, cJun which is important related to MMP1, IL/interleukins in inflammatory pathway, and cytochromes.
  • the attached examples describe the use of the present system for illustrative treatments.
  • the systems and methods of the present invention may be used in combination with various wound dressings like bandage strips modified to have a transparent covering, so that the desired spectra of photomodulation by LED or other light is transmitted to the wounded area of the skin or target tissue.
  • One embodiment includes ‘trap door’ to permit the periodic inhibition of light transmission.
  • the opening or translucent/transparent portion of the bandage may comprise an IR filter, as well. In instances where it is undesirable to include an opening as part of the bandage or wound dressing, the size of LED's and other light sources makes it possible to include a light source within the bandage.
  • Such a source could be powered from a small battery and include means for having the light source automatically or manually apply treatment at regular intervals and according to a variety of preset codes (for example, a dressed chemical burn may require a different code than a cut or electrical burn).
  • various topical compositions for enhancing the penetration of the light through the skin or target tissue can be included in the dressing or bandage or applied to the skin or target tissue prior to covering the affected skin with the bandage or dressing.
  • a light source within the bandage may also be coded to ‘release’ or to ‘activate’ substances or delivery vehicles for substances so that oxygen, antibacterial, antiviral, anti fungal, etc., or other agents released. Combinations of such compositions may be used as well.
  • Another application would allow for the treatment of blood outside of the body (extracorporeally, in a phoresis device for example).
  • the blood may be run through banks of arrays of LED, or other light or EMR, and then photomodulated either directly or by an agent that was photoactivatable, or both, to stimulate the immune system, treat disease, etc.
  • the present system and method may also be used for retinal and other eye treatments, alone or along with antioxidant eyedrop-type medications, bioengineered peptides, and growth factors.
  • Antioxidant eyedrops include, but are not limited to glutathione, vitamin C, vitamin E, catalase, ubiquinone, idebenone, etc.
  • adipocytes for fat reduction, cellulite, etc. may be accomplished using light sources in the range of about 850-950 nm and 1000-100 nm.

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pathology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Biophysics (AREA)
  • Surgery (AREA)
  • Otolaryngology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Radiation-Therapy Devices (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
US10/903,483 2003-07-31 2004-08-02 System and method for the photodynamic treatment of burns, wounds, and related skin disorders Abandoned US20050149150A1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
US10/903,483 US20050149150A1 (en) 2003-07-31 2004-08-02 System and method for the photodynamic treatment of burns, wounds, and related skin disorders
US12/550,464 US9144690B2 (en) 2003-07-31 2009-08-31 System and method for the photodynamic treatment of burns, wounds, and related skin disorders
US14/807,653 US20150328479A1 (en) 2003-07-31 2015-07-23 System and method for the photodynamic treatment of burns, wounds, and related skin disorders

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US49127703P 2003-07-31 2003-07-31
US10/903,483 US20050149150A1 (en) 2003-07-31 2004-08-02 System and method for the photodynamic treatment of burns, wounds, and related skin disorders

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US12/550,464 Continuation US9144690B2 (en) 2003-07-31 2009-08-31 System and method for the photodynamic treatment of burns, wounds, and related skin disorders

Publications (1)

Publication Number Publication Date
US20050149150A1 true US20050149150A1 (en) 2005-07-07

Family

ID=34115488

Family Applications (3)

Application Number Title Priority Date Filing Date
US10/903,483 Abandoned US20050149150A1 (en) 2003-07-31 2004-08-02 System and method for the photodynamic treatment of burns, wounds, and related skin disorders
US12/550,464 Expired - Lifetime US9144690B2 (en) 2003-07-31 2009-08-31 System and method for the photodynamic treatment of burns, wounds, and related skin disorders
US14/807,653 Abandoned US20150328479A1 (en) 2003-07-31 2015-07-23 System and method for the photodynamic treatment of burns, wounds, and related skin disorders

Family Applications After (2)

Application Number Title Priority Date Filing Date
US12/550,464 Expired - Lifetime US9144690B2 (en) 2003-07-31 2009-08-31 System and method for the photodynamic treatment of burns, wounds, and related skin disorders
US14/807,653 Abandoned US20150328479A1 (en) 2003-07-31 2015-07-23 System and method for the photodynamic treatment of burns, wounds, and related skin disorders

Country Status (9)

Country Link
US (3) US20050149150A1 (fr)
EP (1) EP1648385B1 (fr)
JP (1) JP4739202B2 (fr)
KR (1) KR101160343B1 (fr)
CN (1) CN101247768A (fr)
CA (1) CA2533129A1 (fr)
ES (1) ES2572976T3 (fr)
IL (1) IL173123A0 (fr)
WO (1) WO2005011606A2 (fr)

Cited By (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030009205A1 (en) * 1997-08-25 2003-01-09 Biel Merrill A. Treatment device for topical photodynamic therapy and method of using same
US20060167532A1 (en) * 2005-01-26 2006-07-27 Parker Jeffery R Phototherapy treatment devices for applying area lighting to a wound
US20070021807A1 (en) * 2005-07-20 2007-01-25 Eastman Kodak Company Device for optically stimulating collagen formation in tissue
USD585997S1 (en) 2006-10-13 2009-02-03 Light Dimensions, Inc. Light-based dermal enhancing apparatus
US20100104471A1 (en) * 2008-10-27 2010-04-29 Nicholas Harmon Mobile disinfectant device and methods
US20100102252A1 (en) * 2008-10-27 2010-04-29 Nicholas Harmon Hand held sterilization devices
US20100121419A1 (en) * 2008-11-13 2010-05-13 Ryan Douglas Control of light sources for light therapies
US20110046538A1 (en) * 2008-02-06 2011-02-24 L'oreal Combination of a light ray with a cytochrome c oxidase substrate particularly for improving the appearance of the skin and/or hair
US20110196353A1 (en) * 2010-02-05 2011-08-11 Deland Maitland M LED Treatment of Dermatologic Toxicities Associated with Epidermal Growth Factor Receptor Inhibitors
US20110196351A1 (en) * 2010-02-05 2011-08-11 Deland Maitland M LED Treatment of Dermatologic Toxicities Associated with Multikinase Inhibitors
US8330121B2 (en) 2011-05-03 2012-12-11 Verilux, Inc. Dynamic display and control of UV source for sanitization in mobile devices
US8430102B2 (en) 2010-03-31 2013-04-30 Oncologics, Inc. Oral device for radiotherapy
US8496008B2 (en) 2010-03-31 2013-07-30 Oncologics, Inc. Oral device for radiotherapy
US20130324909A1 (en) * 2011-02-14 2013-12-05 Merck Patent Gmbh Device and method for treatment of cells and cell tissue
US8784408B2 (en) 2010-02-05 2014-07-22 M. Maitland DeLand LED treatment of dermatologic toxicities associated with vascular endothelial growth factor inhibitors
US9278232B2 (en) 2011-03-17 2016-03-08 Jk-Holding Gmbh Device for irradiating actinic radiation of different wavelengths
US20160206897A1 (en) * 2005-04-14 2016-07-21 Photospectra Health Sciences, Inc. Ophthalmic phototherapy device and associated treatment method
US20160220804A1 (en) * 2015-02-03 2016-08-04 L'oreal Apparatus and method for skin treatment using continuous light
US20160346565A1 (en) * 2015-05-29 2016-12-01 Nathaniel L.R. Rhodes Methods and apparatus to deliver therapeutic non-ultraviolet electromagnetic radiation to a body surface
US10039600B2 (en) 2015-02-03 2018-08-07 L'oreal Apparatus and method for skin treatment using pulsed light
US10219944B2 (en) 2014-09-09 2019-03-05 LumiThera, Inc. Devices and methods for non-invasive multi-wavelength photobiomodulation for ocular treatments

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6887260B1 (en) 1998-11-30 2005-05-03 Light Bioscience, Llc Method and apparatus for acne treatment
US6283956B1 (en) 1998-11-30 2001-09-04 David H. McDaniels Reduction, elimination, or stimulation of hair growth
US9192780B2 (en) * 1998-11-30 2015-11-24 L'oreal Low intensity light therapy for treatment of retinal, macular, and visual pathway disorders
US20060212025A1 (en) 1998-11-30 2006-09-21 Light Bioscience, Llc Method and apparatus for acne treatment
KR20060041161A (ko) 2003-04-10 2006-05-11 라이트 바이오사이언스, 엘엘씨 세포 증식 및 유전자 발현의 조절을 위한 광조절 방법 및광조절 장치
EP1648385B1 (fr) 2003-07-31 2016-05-04 Gentlewaves Llc Systeme et methode de traitement photodynamique de la peau
WO2006103678A2 (fr) 2005-03-31 2006-10-05 Esther Mayer Dispositif a sonde, systeme et procede de photobiomodulation d'une tunique dans une cavite du corps
CA2686929A1 (fr) 2007-05-11 2008-11-20 Clarimedix Inc. Modulations de la fonction mitochondriale par la lumiere visible dans le traitement de l'hypoxie et autres maladies
EP2200574B1 (fr) * 2007-10-17 2019-06-26 Newtree Co., Ltd. Utilisation nouvelle de dérivés de panduratine ou d'un extrait de kaempferia pandurata en contenant
CN101701183B (zh) * 2009-10-28 2012-07-18 福建师范大学 一种基于led阵列的离体细胞光动力作用效果比照仪
KR101293882B1 (ko) * 2010-06-30 2013-08-06 단국대학교 산학협력단 라이코펜을 포함하는 허혈성 질환의 치료 또는 예방용 조성물
US9687669B2 (en) 2011-11-09 2017-06-27 John Stephan Wearable light therapy apparatus
CN103212162A (zh) * 2012-01-19 2013-07-24 福华电子股份有限公司 混合光刺激方法及混合光刺激装置
FR2997018A1 (fr) 2012-10-23 2014-04-25 Oreal Dispositif et procede de traitement cosmetique par la lumiere
FR2997019B1 (fr) 2012-10-23 2016-07-01 Oreal Dispositif, appareil et procede de traitement cosmetique par la lumiere
SE538469C2 (sv) * 2013-10-07 2016-07-12 Johansson Susanne Anordning för styrning av en laserprob
JP6598450B2 (ja) * 2014-10-28 2019-10-30 花王株式会社 皮膚性状判定のための遺伝子検出方法
KR101666838B1 (ko) 2015-05-13 2016-10-17 대구가톨릭대학교산학협력단 흉터 치료 시스템
KR101762111B1 (ko) * 2015-07-06 2017-07-28 코스맥스 주식회사 동규자 추출물을 함유하는 피부노화 또는 피부주름 개선용 화장료 조성물
BR112018001874B1 (pt) 2015-07-28 2022-10-11 Know Bio, Llc Métodos de modulação de óxido nítrico em tecido vivo de mamífero
ES2836266T3 (es) 2015-07-28 2021-06-24 Know Bio Llc Dispositivos de fototerapia para el tratamiento de trastornos dermatológicos del cuero cabelludo
US12109429B2 (en) 2015-07-28 2024-10-08 Know Bio, Llc Phototherapeutic light for treatment of pathogens
CN109789313A (zh) 2016-07-27 2019-05-21 Z2020有限责任公司 用于光疗递送的部件和装置及其相关的方法
US20190083809A1 (en) 2016-07-27 2019-03-21 Z2020, Llc Componentry and devices for light therapy delivery and methods related thereto
CN108295382A (zh) * 2018-01-04 2018-07-20 华南农业大学 氦氖激光在皮肤创伤治疗中的应用
WO2019236632A1 (fr) * 2018-06-04 2019-12-12 Avon Products. Inc. Biomarqueurs protéiques permettant d'identifier et de traiter une peau vieillissante et des affections cutanées
US12331320B2 (en) 2018-10-10 2025-06-17 The Research Foundation For The State University Of New York Genome edited cancer cell vaccines
FR3106058B1 (fr) 2020-01-09 2022-01-07 Oreal Procédé de traitement cosmétique
US12011611B2 (en) 2020-03-19 2024-06-18 Know Bio, Llc Illumination devices for inducing biological effects
US12447354B2 (en) 2020-03-19 2025-10-21 Know Bio, Llc Illumination devices for inducing biological effects
US11147984B2 (en) 2020-03-19 2021-10-19 Know Bio, Llc Illumination devices for inducing biological effects
US11986666B2 (en) 2020-03-19 2024-05-21 Know Bio, Llc Illumination devices for inducing biological effects
US11975215B2 (en) 2020-05-26 2024-05-07 Know Bio, Llc Devices and related methods for phototherapeutic treatment of skin
US12347337B2 (en) 2020-12-10 2025-07-01 Know Bio, Llc Enhanced testing and characterization techniques for phototherapeutic light treatments
US11654294B2 (en) 2021-03-15 2023-05-23 Know Bio, Llc Intranasal illumination devices
US12115384B2 (en) 2021-03-15 2024-10-15 Know Bio, Llc Devices and methods for illuminating tissue to induce biological effects
US12089716B2 (en) 2022-04-29 2024-09-17 L'oreal Applicator with cartridges configured to deliver vibration for skin treatment
CN118001374A (zh) * 2023-02-13 2024-05-10 上海萨美细胞技术有限公司 一种抗皮肤纤维化的药物

Citations (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5837224A (en) * 1996-01-19 1998-11-17 The Regents Of The University Of Michigan Method of inhibiting photoaging of skin
US6030374A (en) * 1998-05-29 2000-02-29 Mcdaniel; David H. Ultrasound enhancement of percutaneous drug absorption
US6130254A (en) * 1997-06-04 2000-10-10 Regents Of The University Of Michigan Methods for inhibiting photoaging of skin
US6171332B1 (en) * 1992-10-23 2001-01-09 Photo Therapeutics Limited Light source
US6267779B1 (en) * 1999-03-29 2001-07-31 Medelaser, Llc Method and apparatus for therapeutic laser treatment
US6398753B2 (en) * 1998-04-03 2002-06-04 Mcdaniel David H. Ultrasound enhancement of percutaneous drug absorption
US6443978B1 (en) * 1998-04-10 2002-09-03 Board Of Trustees Of The University Of Arkansas Photomatrix device
US6629971B2 (en) * 1998-11-30 2003-10-07 Mcdaniel David Process for stimulating hair growth
US6630516B2 (en) * 1997-02-25 2003-10-07 The Regents Of The University Of Michigan Methods and compositions for preventing and treating chronological aging in human skin
US6645230B2 (en) * 2000-03-23 2003-11-11 Photo Therapeutics Ltd. Therapeutic light source and method
US6663659B2 (en) * 2000-01-13 2003-12-16 Mcdaniel David H. Method and apparatus for the photomodulation of living cells
US6676655B2 (en) * 1998-11-30 2004-01-13 Light Bioscience L.L.C. Low intensity light therapy for the manipulation of fibroblast, and fibroblast-derived mammalian cells and collagen
US6746444B2 (en) * 2000-12-18 2004-06-08 Douglas J. Key Method of amplifying a beneficial selective skin response to light energy
US6835306B2 (en) * 2001-07-06 2004-12-28 Spx Corporation Return-side filter for use in a vehicle transmission
US6887260B1 (en) * 1998-11-30 2005-05-03 Light Bioscience, Llc Method and apparatus for acne treatment
US7147863B2 (en) * 2000-07-06 2006-12-12 Regents Of The University Of Michigan UVA (> 360-400) and UVB (300-325) specific sunscreens
US7354432B2 (en) * 2003-01-17 2008-04-08 Mcw Research Foundation, Inc. Red to near-infrared photobiomodulation treatment of the visual system in visual system disease or injury

Family Cites Families (372)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3499437A (en) 1967-03-10 1970-03-10 Ultrasonic Systems Method and apparatus for treatment of organic structures and systems thereof with ultrasonic energy
US3876907A (en) 1970-12-10 1975-04-08 Controlled Environment Syst Plant growth system
US3930335A (en) 1973-04-02 1976-01-06 Controlled Environment Systems, Inc. Plant growth system
US4309989A (en) 1976-02-09 1982-01-12 The Curators Of The University Of Missouri Topical application of medication by ultrasound with coupling agent
US4069823A (en) 1976-04-19 1978-01-24 Viktor Leonidovich Isakov Apparatus for laser therapy
US4458678A (en) 1981-10-26 1984-07-10 Massachusetts Institute Of Technology Cell-seeding procedures involving fibrous lattices
DE3151494A1 (de) 1981-12-24 1983-07-21 Mutzhas Maximilian F Verfahren zur phototherapie von dermatosen, insbesondere von psoriasis
SE8200913L (sv) 1982-02-16 1983-08-17 Integrerad Teknik Igt Hb Anordning vid lysdioder
US4649151A (en) 1982-09-27 1987-03-10 Health Research, Inc. Drugs comprising porphyrins
DE3306981C2 (de) 1983-02-28 1987-11-12 Wolfram 8048 Haimhausen Weinberg Vorrichtung zur Photokoagulation von biologischem Gewebe
GB2157176A (en) 1984-04-09 1985-10-23 Lasercare Promoting hair growth by laser
US4646743A (en) 1984-05-09 1987-03-03 Parris Danny M Therapy radiation apparatus for veterinary medicine
US4621287A (en) 1984-05-29 1986-11-04 Rca Corporation Time-multiplexing of an interleaved spectrum of a television signal
US4629363A (en) 1984-11-02 1986-12-16 Rose Timothy M Continuous conduit laying apparatus
US4603496A (en) 1985-02-04 1986-08-05 Adaptive Micro Systems, Inc. Electronic display with lens matrix
US4753958A (en) 1985-02-07 1988-06-28 University Of Cal Photochemotherapy of epithelial diseases with derivatives of hematoporphyrins
DE3603156A1 (de) 1986-02-03 1987-08-06 Zeiss Carl Fa Vorrichtung zur therapeutischen bestrahlung von organischem gewebe mit laserstrahlung
US5460939A (en) 1986-04-18 1995-10-24 Advanced Tissue Sciences, Inc. Temporary living skin replacement
US5266480A (en) 1986-04-18 1993-11-30 Advanced Tissue Sciences, Inc. Three-dimensional skin culture system
JPS633873A (ja) 1986-06-23 1988-01-08 富士電機株式会社 レ−ザ−治療器
US4767402A (en) 1986-07-08 1988-08-30 Massachusetts Institute Of Technology Ultrasound enhancement of transdermal drug delivery
JPS63111886A (ja) 1986-10-29 1988-05-17 呉羽化学工業株式会社 光ダイオ−ドを用いた癌治療装置
US5283255A (en) 1987-01-20 1994-02-01 The University Of British Columbia Wavelength-specific cytotoxic agents
EP0298661B1 (fr) 1987-07-08 1994-06-15 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Système vibratoire et dispositif vibrothérapeutique l'utilisant
US4764379A (en) 1987-08-24 1988-08-16 Alza Corporation Transdermal drug delivery device with dual permeation enhancers
US5001556A (en) 1987-09-30 1991-03-19 Olympus Optical Co., Ltd. Endoscope apparatus for processing a picture image of an object based on a selected wavelength range
US5259380A (en) 1987-11-04 1993-11-09 Amcor Electronics, Ltd. Light therapy system
US4837027A (en) 1987-11-09 1989-06-06 Alza Corporation Transdermal drug delivery device
US4781924A (en) 1987-11-09 1988-11-01 Alza Corporation Transdermal drug delivery device
US4930504A (en) 1987-11-13 1990-06-05 Diamantopoulos Costas A Device for biostimulation of tissue and method for treatment of tissue
JPH07100219B2 (ja) 1987-11-25 1995-11-01 石川島播磨重工業株式会社 薄板製造装置
IT212331Z2 (it) 1987-11-27 1989-07-04 Lorenzo Molinari Apparecchiatura per asportare in modo regolabile porzioni superficiali di tessuto umano
US4888354A (en) 1987-12-21 1989-12-19 Theratech, Inc. Skin penetration enhancement using free base and acid addition salt combinations of active agents
US4935665A (en) 1987-12-24 1990-06-19 Mitsubishi Cable Industries Ltd. Light emitting diode lamp
US4969912A (en) 1988-02-18 1990-11-13 Kelman Charles D Human collagen processing and autoimplant use
US4907132A (en) 1988-03-22 1990-03-06 Lumitex, Inc. Light emitting panel assemblies and method of making same
US5198460A (en) 1988-07-20 1993-03-30 Health Research Inc. Pyropheophorbides and their use in photodynamic therapy
US5147349A (en) 1988-10-07 1992-09-15 Spectra-Physics, Inc. Diode laser device for photocoagulation of the retina
US5012609A (en) 1988-12-12 1991-05-07 Automated Agriculture Associates, Inc. Method and apparatus for irradiation of plants using optoelectronic devices
US5021452A (en) 1989-01-09 1991-06-04 The Board Of Regents Of The University Of Washington Process for enhancing wound healing
US6099522A (en) 1989-02-06 2000-08-08 Visx Inc. Automated laser workstation for high precision surgical and industrial interventions
US5034613A (en) 1989-11-14 1991-07-23 Cornell Research Foundation, Inc. Two-photon laser microscopy
US5257173A (en) 1989-12-13 1993-10-26 Stanley Electric Co., Ltd. Light irradiating apparatus having light emitting diode used as light source
JPH0716304Y2 (ja) 1990-01-19 1995-04-12 富士通株式会社 メモリ回路の保護構造
US5016615A (en) 1990-02-20 1991-05-21 Riverside Research Institute Local application of medication with ultrasound
US5115805A (en) 1990-02-23 1992-05-26 Cygnus Therapeutic Systems Ultrasound-enhanced delivery of materials into and through the skin
US5231975A (en) 1990-02-23 1993-08-03 Cygnus Therapeutic Systems Ultrasound-enhanced delivery of materials into and through the skin
JPH05505737A (ja) * 1990-03-14 1993-08-26 キャンデラ・コーポレーション パルス照射を利用した色素沈着した損傷を治療する装置及び方法
US5071416A (en) 1990-05-02 1991-12-10 Metalaser Technologies, Inc. Method of and apparatus for laser-assisted therapy
US5549660A (en) 1990-11-15 1996-08-27 Amron, Ltd. Method of treating acne
US5500009A (en) 1990-11-15 1996-03-19 Amron, Ltd. Method of treating herpes
US6723698B2 (en) 1991-03-11 2004-04-20 Curis, Inc. Methods and compositions for the treatment of motor neuron injury and neuropathy
JP2774695B2 (ja) 1991-03-29 1998-07-09 コラーゲン コーポレイション 顔のしわを処置する装置および方法
US5198465A (en) 1991-06-19 1993-03-30 Dioguardi Francesco S Compositions based on amino acids for preventing and treating precursor deficiencies in the synthesis of collagen
US5262401A (en) 1991-06-28 1993-11-16 Cytopharm, Inc. Porphycene compounds for photodynamic therapy
US5951596A (en) 1991-07-01 1999-09-14 Laser Biotherapy Inc Biological tissue stimulation by optical energy
US5445146A (en) 1995-03-31 1995-08-29 Bellinger; Gary J. Biological tissue stimulation by low level optical energy
US5171215A (en) 1991-08-22 1992-12-15 Flanagan Dennis F Endermic method and apparatus
US5370642A (en) 1991-09-25 1994-12-06 Keller; Gregory S. Method of laser cosmetic surgery
US5423803A (en) 1991-10-29 1995-06-13 Thermotrex Corporation Skin surface peeling process using laser
US5752949A (en) 1991-10-29 1998-05-19 Thermolase Corporation Hair removal method
US5226907A (en) 1991-10-29 1993-07-13 Tankovich Nikolai I Hair removal device and method
US5817089A (en) 1991-10-29 1998-10-06 Thermolase Corporation Skin treatment process using laser
US5752948A (en) 1991-10-29 1998-05-19 Thermolase Corporation Hair removal method
US5425728A (en) 1991-10-29 1995-06-20 Tankovich; Nicolai I. Hair removal device and method
US5871480A (en) 1991-10-29 1999-02-16 Thermolase Corporation Hair removal using photosensitizer and laser
US5279538A (en) 1991-11-18 1994-01-18 E. I. Du Pont De Nemours And Company Centrifuge rotor having a predetermined region of failure
CH685148A5 (de) 1991-11-20 1995-04-13 Erik Larsen Vorrichtung zur fotodynamischen Stimulierung von Zellen.
GB2262043B (en) 1991-12-02 1995-08-16 John A Orpin Pulsed energy stimulator device
IL100545A (en) 1991-12-29 1995-03-15 Dimotech Ltd Photodynamic Healing Therapy Device
US5756117A (en) 1992-04-08 1998-05-26 International Medical Asscociates, Inc. Multidose transdermal drug delivery system
US5405368A (en) 1992-10-20 1995-04-11 Esc Inc. Method and apparatus for therapeutic electromagnetic treatment
US5755752A (en) 1992-04-24 1998-05-26 Segal; Kim Robin Diode laser irradiation system for biological tissue stimulation
WO1993021842A1 (fr) 1992-04-30 1993-11-11 Quadra Logic Technologies, Inc. Diodes electroluminescentes tres puissantes destinees a la therapie photodynamique
DE4223004A1 (de) 1992-07-13 1994-01-20 Liedtke Pharmed Gmbh Einzeldosierte halbfeste topische Arzneiform zur Transdermaltherapie
US5278432A (en) 1992-08-27 1994-01-11 Quantam Devices, Inc. Apparatus for providing radiant energy
US5492135A (en) 1992-09-09 1996-02-20 Devore; Dale P. Collagen modulators for use in photoablation excimer laser keratectomy
US5421816A (en) 1992-10-14 1995-06-06 Endodermic Medical Technologies Company Ultrasonic transdermal drug delivery system
US5620478A (en) 1992-10-20 1997-04-15 Esc Medical Systems Ltd. Method and apparatus for therapeutic electromagnetic treatment
US5683380A (en) 1995-03-29 1997-11-04 Esc Medical Systems Ltd. Method and apparatus for depilation using pulsed electromagnetic radiation
US5360824A (en) 1993-02-05 1994-11-01 Barker Donald E Human skin cleansing and wrinkle-reducing cream
US5445608A (en) 1993-08-16 1995-08-29 James C. Chen Method and apparatus for providing light-activated therapy
US5397352A (en) 1993-08-27 1995-03-14 Burres; Steven Method of recollagenation
US5420768A (en) 1993-09-13 1995-05-30 Kennedy; John Portable led photocuring device
US5647866A (en) 1993-11-09 1997-07-15 Zaias; Nardo Method of hair depilation
US5814599A (en) 1995-08-04 1998-09-29 Massachusetts Insitiute Of Technology Transdermal delivery of encapsulated drugs
US5445611A (en) 1993-12-08 1995-08-29 Non-Invasive Monitoring Company (Nimco) Enhancement of transdermal delivery with ultrasound and chemical enhancers
SE504298C2 (sv) 1994-01-20 1996-12-23 Biolight Patent Holding Ab Anordning för sårläkning medelst ljus
SE502784C2 (sv) 1994-01-20 1996-01-15 Biolight Patent Holding Ab Anordning för medicinsk behandling utvärtes medelst ljus
US5358503A (en) 1994-01-25 1994-10-25 Bertwell Dale E Photo-thermal therapeutic device and method
IL108918A (en) 1994-03-10 1997-04-15 Medic Lightech Ltd Apparatus for efficient photodynamic treatment
US5616140A (en) 1994-03-21 1997-04-01 Prescott; Marvin Method and apparatus for therapeutic laser treatment
US5474528A (en) 1994-03-21 1995-12-12 Dusa Pharmaceuticals, Inc. Combination controller and patch for the photodynamic therapy of dermal lesion
US5586981A (en) * 1994-08-25 1996-12-24 Xin-Hua Hu Treatment of cutaneous vascular and pigmented lesions
US5698866A (en) 1994-09-19 1997-12-16 Pdt Systems, Inc. Uniform illuminator for phototherapy
US5669916A (en) 1994-09-28 1997-09-23 The General Hospital Corporation Method of hair removal
WO1996011723A1 (fr) 1994-10-17 1996-04-25 Australasian Medical Technology Limited Methodes et dispositifs pour la mise en ×uvre d'une therapeutique fondee sur l'application de champ electromagnetique par impulsions
US5660461A (en) 1994-12-08 1997-08-26 Quantum Devices, Inc. Arrays of optoelectronic devices and method of making same
US5643334A (en) 1995-02-07 1997-07-01 Esc Medical Systems Ltd. Method and apparatus for the diagnostic and composite pulsed heating and photodynamic therapy treatment
US5728090A (en) 1995-02-09 1998-03-17 Quantum Devices, Inc. Apparatus for irradiating living cells
JP3670064B2 (ja) * 1995-03-15 2005-07-13 啓介 小林 生体用光線照射装置及びそのランプ
US5660836A (en) 1995-05-05 1997-08-26 Knowlton; Edward W. Method and apparatus for controlled contraction of collagen tissue
US5658323A (en) 1995-07-12 1997-08-19 Miller; Iain D. Method and apparatus for dermatology treatment
US5947921A (en) 1995-12-18 1999-09-07 Massachusetts Institute Of Technology Chemical and physical enhancers and ultrasound for transdermal drug delivery
US6008211A (en) 1995-07-27 1999-12-28 Pdt Pharmaceuticals, Inc. Photoactivatable compounds comprising benzochlorin and furocoumarin
US5591444A (en) 1995-07-28 1997-01-07 Isolagen Technologies, Inc. Use of autologous dermal fibroblasts for the repair of skin and soft tissue defects
US20070208328A1 (en) 1995-08-31 2007-09-06 Dmitri Boutoussov Contra-angel rotating handpiece having tactile-feedback tip ferrule
US5849029A (en) 1995-12-26 1998-12-15 Esc Medical Systems, Ltd. Method for controlling the thermal profile of the skin
US5964749A (en) 1995-09-15 1999-10-12 Esc Medical Systems Ltd. Method and apparatus for skin rejuvenation and wrinkle smoothing
US5836999A (en) 1995-09-28 1998-11-17 Esc Medical Systems Ltd. Method and apparatus for treating psoriasis using pulsed electromagnetic radiation
US5618275A (en) 1995-10-27 1997-04-08 Sonex International Corporation Ultrasonic method and apparatus for cosmetic and dermatological applications
US6143287A (en) 1996-02-27 2000-11-07 New York Blood Center, Inc. Method and composition for hair removal
US5800478A (en) 1996-03-07 1998-09-01 Light Sciences Limited Partnership Flexible microcircuits for internal light therapy
US5843072A (en) 1996-11-07 1998-12-01 Cynosure, Inc. Method for treatment of unwanted veins and device therefor
AU711767B2 (en) 1996-04-11 1999-10-21 Nikolai Taimourasovich Bagraev Method for treating pathological tissues with device to effect same
US5766214A (en) 1996-04-18 1998-06-16 Mehl, Sr.; Thomas L. Melanin enhanced photothermolysis hair removal
ATE398459T1 (de) 1996-04-26 2008-07-15 Univ Ottawa Verwendung von naip oder iap für die behandlung und vorbeugung von neuronalen erkrankungen
US5662644A (en) * 1996-05-14 1997-09-02 Mdlt, Inc. Dermatological laser apparatus and method
SE509003C2 (sv) 1996-06-07 1998-11-23 Biolight Patent Holding Ab Anordning för medicinsk utvärtes behandling medelst monokromatiskt ljus
SE509718C2 (sv) 1996-06-07 1999-03-01 Biolight Patent Holding Ab Anordning för medicinsk utvärtes ljusbehandling
US5913883A (en) 1996-08-06 1999-06-22 Alexander; Dane Therapeutic facial mask
GB9618051D0 (en) * 1996-08-29 1996-10-09 Sls Wales Ltd Wrinkle removal
US6214034B1 (en) 1996-09-04 2001-04-10 Radiancy, Inc. Method of selective photothermolysis
KR100487012B1 (ko) 1996-09-11 2005-06-16 마츠시타 덴끼 산교 가부시키가이샤 프로그램의일부만수신한상태에서도당해프로그램을실행개시할수있는프로그램수신실행장치및그를위한프로그램송신장치
US5665053A (en) 1996-09-27 1997-09-09 Jacobs; Robert A. Apparatus for performing endermology with ultrasound
ES2202640T3 (es) 1996-10-01 2004-04-01 Wyeth Lederle Japan Ltd. Derivados de acido iminoclorina aspartico.
US6024717A (en) 1996-10-24 2000-02-15 Vibrx, Inc. Apparatus and method for sonically enhanced drug delivery
US5829448A (en) 1996-10-30 1998-11-03 Photogen, Inc. Method for improved selectivity in photo-activation of molecular agents
US7036516B1 (en) 1996-10-30 2006-05-02 Xantech Pharmaceuticals, Inc. Treatment of pigmented tissues using optical energy
GB9623627D0 (en) 1996-11-13 1997-01-08 Meditech International Inc Method and apparatus for photon therapy
US8182473B2 (en) 1999-01-08 2012-05-22 Palomar Medical Technologies Cooling system for a photocosmetic device
US20060149343A1 (en) 1996-12-02 2006-07-06 Palomar Medical Technologies, Inc. Cooling system for a photocosmetic device
US20080294152A1 (en) 1996-12-02 2008-11-27 Palomar Medical Technologies, Inc. Cooling System For A Photocosmetic Device
US7204832B2 (en) 1996-12-02 2007-04-17 Pálomar Medical Technologies, Inc. Cooling system for a photo cosmetic device
US6050990A (en) 1996-12-05 2000-04-18 Thermolase Corporation Methods and devices for inhibiting hair growth and related skin treatments
US6190376B1 (en) 1996-12-10 2001-02-20 Asah Medico A/S Apparatus for tissue treatment
US6063108A (en) * 1997-01-06 2000-05-16 Salansky; Norman Method and apparatus for localized low energy photon therapy (LEPT)
US5997569A (en) 1997-01-29 1999-12-07 Light Sciences Limited Partnership Flexible and adjustable grid for medical therapy
US5810801A (en) 1997-02-05 1998-09-22 Candela Corporation Method and apparatus for treating wrinkles in skin using radiation
US5904659A (en) 1997-02-14 1999-05-18 Exogen, Inc. Ultrasonic treatment for wounds
US5957960A (en) 1997-05-05 1999-09-28 Light Sciences Limited Partnership Internal two photon excitation device for delivery of PDT to diffuse abnormal cells
US6235015B1 (en) * 1997-05-14 2001-05-22 Applied Optronics Corporation Method and apparatus for selective hair depilation using a scanned beam of light at 600 to 1000 nm
DK0991372T3 (da) 1997-05-15 2004-12-06 Palomar Medical Tech Inc Apparat til dermatologisk behandling
US6312450B1 (en) 1997-05-20 2001-11-06 Natural Vision Center, Inc. System and method for improving the appearance of skin
EP1018955A4 (fr) 1997-06-24 2001-06-20 Laser Aesthetics Inc Lampe a incandescence pulsee pour traitement dermatologique
US5954675A (en) 1997-07-07 1999-09-21 Dellagatta; Enrico Michael Method of ultrasonic therapy
AU750933B2 (en) 1997-07-28 2002-08-01 Dermatolazer Technologies Ltd. Phototherapy based method for treating pathogens and composition for effecting same
US6251127B1 (en) 1997-08-25 2001-06-26 Advanced Photodynamic Technologies, Inc. Dye treatment solution and photodynamic therapy and method of using same
US6074382A (en) 1997-08-29 2000-06-13 Asah Medico A/S Apparatus for tissue treatment
CA2305721C (fr) 1997-10-08 2009-02-24 The General Hospital Corporation Procedes et systemes de phototherapie
GB9721506D0 (en) 1997-10-10 1997-12-10 Virulite Limited Treatment of diseases
IL122016A (en) 1997-10-22 2001-09-13 Tav Tech Ltd Apparatus for dermal abrasion
US6113559A (en) 1997-12-29 2000-09-05 Klopotek; Peter J. Method and apparatus for therapeutic treatment of skin with ultrasound
JP2002500075A (ja) 1998-01-08 2002-01-08 ソントラ メディカル， インコーポレイテッド 超音波伝達で増強される経皮輸送
EP1051599B1 (fr) 1998-01-27 2002-01-02 KAAS, Povl Dispositif de mesure de l'intensite des rayons uv d'une lampe et installation de traitement par uv equipee de ce dispositif
US20020055702A1 (en) 1998-02-10 2002-05-09 Anthony Atala Ultrasound-mediated drug delivery
EP1566149A1 (fr) 1998-03-12 2005-08-24 Palomar Medical Technologies, Inc. Système d'application de rayonnement électromagnétique sur la peau
US6223071B1 (en) 1998-05-01 2001-04-24 Dusa Pharmaceuticals Inc. Illuminator for photodynamic therapy and diagnosis which produces substantially uniform intensity visible light
US7004933B2 (en) 1998-05-29 2006-02-28 Light Bioscience L.L.C. Ultrasound enhancement of percutaneous drug absorption
US6110106A (en) 1998-06-24 2000-08-29 Biomax Technologies, Inc. Endoscopes and methods relating to direct viewing of a target tissue
ATE428345T1 (de) 1998-07-09 2009-05-15 Curelight Medical Ltd Vorrichtung und verfahren zur wirkungsvollen hochenergetischen photodynamischen therapie von akne vulgaris und seborrhoe
EP1102608A4 (fr) 1998-07-13 2008-09-17 Genetronics Inc Procede et appareil d'apport topique dote d'une assistance electrique d'agents destines a des applications cosmetiques
EP1096897A1 (fr) 1998-07-13 2001-05-09 Nobel Biocare AB Systeme universel de chape a empreintes
US6048301A (en) 1998-07-13 2000-04-11 Sabuda; Thomas J. Method and device for stimulating biological processes
US6096066A (en) 1998-09-11 2000-08-01 Light Sciences Limited Partnership Conformal patch for administering light therapy to subcutaneous tumors
JP2000202044A (ja) * 1998-11-10 2000-07-25 Ya Man Ltd レ―ザ育毛装置
US20060212025A1 (en) 1998-11-30 2006-09-21 Light Bioscience, Llc Method and apparatus for acne treatment
US6936044B2 (en) 1998-11-30 2005-08-30 Light Bioscience, Llc Method and apparatus for the stimulation of hair growth
US9192780B2 (en) 1998-11-30 2015-11-24 L'oreal Low intensity light therapy for treatment of retinal, macular, and visual pathway disorders
US6402739B1 (en) 1998-12-08 2002-06-11 Y-Beam Technologies, Inc. Energy application with cooling
US6183773B1 (en) 1999-01-04 2001-02-06 The General Hospital Corporation Targeting of sebaceous follicles as a treatment of sebaceous gland disorders
SE522249C2 (sv) * 1999-01-13 2004-01-27 Biolight Patent Holding Ab Styranordning för styrning av utvärters behandling medelst ljus
US6231528B1 (en) 1999-01-15 2001-05-15 Jonathan J. Kaufman Ultrasonic and growth factor bone-therapy: apparatus and method
AU2412800A (en) 1999-01-15 2000-08-01 Light Sciences Corporation Noninvasive vascular therapy
SE515991C2 (sv) * 1999-01-20 2001-11-05 Biolight Patent Holding Ab Organ för medicinsk behandling utvärtes medelst ljus
US6187029B1 (en) 1999-03-02 2001-02-13 Physician's Technology, Llc Photo-thermal treatment device
GB9905173D0 (en) * 1999-03-05 1999-04-28 Sls Biophile Limited Wrinkle reduction
US7041094B2 (en) 1999-03-15 2006-05-09 Cutera, Inc. Tissue treatment device and method
US6162212A (en) * 1999-04-19 2000-12-19 Esc Medical Systems, Ltd. Optimal procedure for performing a hair removal
CA2369792A1 (fr) * 1999-04-27 2000-11-02 The General Hospital Corporation Methode de traitement phototherapeutique de l'acne
GB9912877D0 (en) 1999-06-04 1999-08-04 Sls Biophile Limited Tissue rejuvenation
US20040122492A1 (en) 1999-07-07 2004-06-24 Yoram Harth Phototherapeutic treatment of skin conditions
US20020173833A1 (en) 1999-07-07 2002-11-21 Avner Korman Apparatus and method for high energy photodynamic therapy of acne vulgaris, seborrhea and other skin disorders
US6290713B1 (en) 1999-08-24 2001-09-18 Thomas A. Russell Flexible illuminators for phototherapy
IL133253A0 (en) 1999-12-01 2001-04-30 Yeda Res & Dev Chlorophyll and bacteriochlorophyll esters, their preparation and pharmaceutical compositions comprising them
US20030036749A1 (en) 1999-12-10 2003-02-20 Durkin Anthony J. Method of treating disorders associated with sebaceous follicles
US6497719B2 (en) 2001-03-06 2002-12-24 Henry Pearl Apparatus and method for stimulating hair growth
JP2001268812A (ja) 2000-03-23 2001-09-28 Sanyo Electric Co Ltd 電池を内蔵する携帯電気機器
US6719749B1 (en) 2000-06-01 2004-04-13 Medical Components, Inc. Multilumen catheter assembly and methods for making and inserting the same
ES2620785T3 (es) 2000-06-01 2017-06-29 The General Hospital Corporation Fotocoagulación selectiva
US6471716B1 (en) 2000-07-11 2002-10-29 Joseph P. Pecukonis Low level light therapy method and apparatus with improved wavelength, temperature and voltage control
US6413268B1 (en) 2000-08-11 2002-07-02 Raymond A. Hartman Apparatus and method for targeted UV phototherapy of skin disorders
US6723798B1 (en) 2000-08-28 2004-04-20 Korean Research Institute Of Chemical Technology Resins having vinyl ether linker for the solid phase organic synthesis
US6602275B1 (en) 2000-09-18 2003-08-05 Jana Sullivan Device and method for therapeutic treatment of living organisms
US6524330B1 (en) 2000-10-27 2003-02-25 Bahram Khoobehi Method of ocular treatment
US6529543B1 (en) 2000-11-21 2003-03-04 The General Hospital Corporation Apparatus for controlling laser penetration depth
AU2002245119A1 (en) 2000-12-15 2002-07-30 Sloan-Kettering Institute For Cancer Research Beam-steering of multi-chromatic light using acousto-optical deflectors and dispersion-compensatory optics
ES2274915T3 (es) 2000-12-28 2007-06-01 Palomar Medical Technologies, Inc. Aparato de tratamiento por radiacion electromagnetica (emr) de la piel.
US9561386B2 (en) 2001-03-06 2017-02-07 Lexington International, Llc Apparatus and method for stimulating hair growth
DE10123926A1 (de) 2001-03-08 2002-09-19 Optomed Optomedical Systems Gmbh Bestrahlungsanordnung
GB0113121D0 (en) 2001-05-30 2001-07-18 Univ Leeds Biologically active photosensitisers
AU2002316384A1 (en) * 2001-06-26 2003-03-03 Photomed Technologies, Inc. Multiple wavelength illuminator
JP2005503849A (ja) 2001-06-27 2005-02-10 レイディアンシー インク． 座瘡治療
US20030009158A1 (en) 2001-07-09 2003-01-09 Perricone Nicholas V. Skin treatments using blue and violet light
US7195755B2 (en) 2001-08-20 2007-03-27 L'oreal S.A. Compositions comprising at least one hydroxide compound and at least one reducing agent, and methods for relaxing hair
KR20040048888A (ko) 2001-08-22 2004-06-10 라이트 바이오사이언스 인코포레이티드 여드름의 치료방법 및 치료용 장치
US7264629B2 (en) 2001-11-09 2007-09-04 Qlt, Inc. Photodynamic therapy for the treatment of hair loss
US6960201B2 (en) 2002-02-11 2005-11-01 Quanticum, Llc Method for the prevention and treatment of skin and nail infections
US7081128B2 (en) 2002-03-04 2006-07-25 Hart Barry M Phototherapy device and method of use
US20070213696A1 (en) 2006-03-10 2007-09-13 Palomar Medical Technologies, Inc. Photocosmetic device
US6664217B1 (en) 2002-07-18 2003-12-16 Unilever Home & Personal Care, Usa Division Of Conopco, Inc. Toilet bar having simultaneous exfoliating and moisturizing properties
US20070219605A1 (en) 2006-03-20 2007-09-20 Palomar Medical Technologies, Inc. Treatment of tissue volume with radiant energy
CN1723058A (zh) 2002-10-07 2006-01-18 帕洛玛医疗技术公司 用于进行光生物刺激的设备
US7131990B2 (en) 2002-10-07 2006-11-07 Natus Medical Inc. Phototherapy system and device
US6866678B2 (en) 2002-12-10 2005-03-15 Interbational Technology Center Phototherapeutic treatment methods and apparatus
US7267673B2 (en) 2002-12-12 2007-09-11 Pacific Biosciences Laboratories, Inc. System for treatment of acne skin condition using a narrow band light source
US20040147985A1 (en) * 2003-01-27 2004-07-29 Altus Medical, Inc. Dermatological treatment flashlamp device and method
US7014639B2 (en) 2003-02-25 2006-03-21 Skincare Technology, Inc. Apparatus for aesthetic skin treatments
US20070038269A1 (en) 2003-02-26 2007-02-15 Photo Therapeutics Ltd. Therapeutic method and apparatus
KR100495815B1 (ko) 2003-02-26 2005-06-16 황하욱 모발 생성기
US7354433B2 (en) 2003-02-28 2008-04-08 Advanced Light Technologies, Llc Disinfection, destruction of neoplastic growth, and sterilization by differential absorption of electromagnetic energy
ES2362825T3 (es) 2003-03-27 2011-07-13 The General Hospital Corporation Aparato y tratamiento dermatológico y renovación fraccionada de la piel.
KR20060041161A (ko) 2003-04-10 2006-05-11 라이트 바이오사이언스, 엘엘씨 세포 증식 및 유전자 발현의 조절을 위한 광조절 방법 및광조절 장치
US7220778B2 (en) 2003-04-15 2007-05-22 The General Hospital Corporation Methods and devices for epithelial protection during photodynamic therapy
US6861658B2 (en) 2003-05-24 2005-03-01 Peter D. Fiset Skin tanning and light therapy incorporating light emitting diodes
DE10349710A1 (de) 2003-05-28 2004-12-16 HELBO Medizintechnik GmbH Anordnung zur Reduktion von Mikroorganismen
EP1648385B1 (fr) 2003-07-31 2016-05-04 Gentlewaves Llc Systeme et methode de traitement photodynamique de la peau
US20080275532A1 (en) 2003-09-12 2008-11-06 Ya-Man Ltd. Treatment Device
GB2408209A (en) 2003-11-18 2005-05-25 Qinetiq Ltd Flexible medical light source
US7326199B2 (en) 2003-12-22 2008-02-05 Cutera, Inc. System and method for flexible architecture for dermatologic treatments utilizing multiple light sources
US7220254B2 (en) 2003-12-31 2007-05-22 Palomar Medical Technologies, Inc. Dermatological treatment with visualization
JP2007521124A (ja) 2004-02-06 2007-08-02 シフィックス リミテッド ライアビリティ カンパニー 電気エネルギー、光エネルギー、および音響エネルギーのうち少なくともいずれか１つを用いる視覚障害の治療
EP1718366A4 (fr) 2004-02-06 2007-11-21 Daniel Barolet Procede et dispositif pour le traitement de tissus mammaliens
JP4971133B2 (ja) 2004-04-01 2012-07-11 ザ ジェネラル ホスピタル コーポレイション 皮膚科治療のための装置
US20090088733A1 (en) 2004-04-03 2009-04-02 Richard Rox Anderson Methods and apparatus for treatment of ocular melanosis
US20070179482A1 (en) 2004-05-07 2007-08-02 Anderson Robert S Apparatuses and methods to treat biological external tissue
EP1750611A4 (fr) 2004-05-13 2008-05-14 Waverx Inc Appareil et procede permettant de traiter une maladie infectieuse dans le tissu corne
EP1793759A4 (fr) 2004-05-19 2010-01-13 Ostern Co Ltd Irradiateur laser faible puissance pour le traitement de l'alopecie
GB0414113D0 (en) 2004-06-24 2004-07-28 Virulite Distrib Ltd Cosmetic uses of electromagnetic radiation
TW200612861A (en) 2004-07-16 2006-05-01 Johnson & Johnson Consumer Treatment of skin with light and a benefit agent
GB2416699B (en) 2004-08-05 2010-04-14 Photo Therapeutics Ltd Skin rejuvenation
AU2005272929A1 (en) 2004-08-09 2006-02-23 Lumiport, Llc Skin treatment phototherapy device
US20070231255A1 (en) 2004-08-13 2007-10-04 Derma Laser Inc Method for the Treatment of Mammalian Skin Tissues Via Pulse Irradiation in the Presence of a Photoactive Compound
CN101223464A (zh) 2004-09-18 2008-07-16 生物激光科技公司 与电磁能程序设备一起使用的编码输出附件
US20060265030A1 (en) 2004-11-12 2006-11-23 Light Bioscience, Llc System and method for photodynamic cell therapy
TWI268787B (en) 2004-12-30 2006-12-21 Ind Tech Res Inst Light therapeutic device
US20060173514A1 (en) 2005-02-02 2006-08-03 Advanced Photodynamic Technologies, Inc. Wound treatment device for photodynamic therapy and method of using same
US7258695B2 (en) 2005-02-08 2007-08-21 Sonetics International Hair restoration device and methods of using and manufacturing the same
EP1693016A1 (fr) 2005-02-16 2006-08-23 Wavelight Laser Technologie AG Dispositif d'irradiation médical et/ou cosmétique
US20060206171A1 (en) 2005-03-14 2006-09-14 Michael Gertner Devices, methods and kits for radiation treatment via a target body surface
US20080294150A1 (en) 2005-04-01 2008-11-27 Palomar Medical Technologies, Inc. Photoselective Islets In Skin And Other Tissues
US7856985B2 (en) 2005-04-22 2010-12-28 Cynosure, Inc. Method of treatment body tissue using a non-uniform laser beam
EP1888172A4 (fr) 2005-05-17 2010-01-06 Photon Therapy Systems Proprietary Ltd Dispositif de therapie photonique
EP1896130B1 (fr) 2005-06-17 2010-11-24 Marcello Rinaldo Baldacchini Dispositif pour le traitement du corps humain avec des ondes électromagnétiques
RU2314844C2 (ru) 2005-07-20 2008-01-20 Общество с ограниченной ответственностью "Дипольные структуры" Способ стимулирования основных биохимических реакций организма для лечения и регенерации тканей, панель для лечения и регенерации тканей и излучатель
US20090125085A1 (en) 2005-07-29 2009-05-14 Technodesign Srl Lighting system for tubs designed to provide well-being with relaxation techniques
CN101355983A (zh) 2005-08-03 2009-01-28 诺密尔医药技术公司 结合医疗设备使用的近红外除菌激光系统(nimels)
EP1945302A4 (fr) 2005-09-30 2009-09-09 Straalen Jason Van Appareil de photothérapie
US20070208395A1 (en) 2005-10-05 2007-09-06 Leclerc Norbert H Phototherapy Device and Method of Providing Phototherapy to a Body Surface
WO2007044840A2 (fr) 2005-10-10 2007-04-19 Reliant Technologies, Inc. Élimination de contenu transépidermique induite par laser par photothermolyse fractionnelle
US20070129776A1 (en) 2005-10-20 2007-06-07 Light Sciences Llc External wearable light therapy treatment systems
US20070156208A1 (en) 2005-11-08 2007-07-05 David Havell Method and Apparatus for Bi-Axial Light Treatment
JP2007151807A (ja) 2005-12-05 2007-06-21 Univ Meijo 半導体発光素子による光線治療方法、及び半導体発光素子による光線治療システム
US20070149901A1 (en) 2005-12-08 2007-06-28 Em-Probe, Inc. Methods and apparatus for pulsed electromagnetic therapy
CN1788645A (zh) 2005-12-12 2006-06-21 林哲文 导光发梳
US20070168000A1 (en) 2006-01-13 2007-07-19 Happawana Gemunu S Apparatus and method for cooling lasers using insulator fluid
US7559945B2 (en) 2006-01-13 2009-07-14 Clarimedix Inc. Multi-spectral photon therapy device and methods of use
US20070173912A1 (en) 2006-01-20 2007-07-26 Somnuk Amornsiripanitch Phototherapy with specific infrared light for treating skin disorders
AU2007208264A1 (en) 2006-01-24 2007-08-02 Nomir Medical Technologies, Inc. Optical method and device for modulation of biochemical processes in adipose tissue
US20070179574A1 (en) 2006-01-30 2007-08-02 Elliott Donald B Apparatus for phototherapeutic treatment of skin disorders
US20090254154A1 (en) 2008-03-18 2009-10-08 Luis De Taboada Method and apparatus for irradiating a surface with pulsed light
EP1818077A1 (fr) 2006-02-03 2007-08-15 WaveLight AG Dispositif de photothérapie pour le traitement de la peau
RU2478406C2 (ru) 2006-02-06 2013-04-10 Конинклейке Филипс Электроникс Н.В. Покрытие тела, очки и/или по меньшей мере частичное покрытие головы, способ облучения по меньшей мере части человеческого тела и использование покрытия тела
EP1988968B1 (fr) 2006-02-22 2011-09-14 Spencer Forrest, Inc. Dispositif de traitement par laser des cheveux et du cuir chevelu
ITFI20060053A1 (it) 2006-02-27 2007-08-28 Cesare Ragazzi Strumento per il trattamento di affezioni dello scalpo
WO2007103721A2 (fr) 2006-03-01 2007-09-13 The General Hospital Corporation systeme et procede pour fournir une therapie laser specifique a une cellule de plaques atherosclereuses par le ciblage des absorbeurs de lumiere dans des macrophages
US20070208396A1 (en) 2006-03-03 2007-09-06 Gary Whatcott Systems and methods for providing a dynamic light pad
US20080031833A1 (en) 2006-03-13 2008-02-07 Oblong John E Combined energy and topical composition application for regulating the condition of mammalian skin
EP1837050A1 (fr) 2006-03-24 2007-09-26 WaveLight AG Dispositif pour l'irradiation de la peau
EP1839705A1 (fr) 2006-03-27 2007-10-03 Universidad de Alcala Emplâtre cutané de thérapie laser
ITBO20060217A1 (it) 2006-03-30 2007-09-30 Espansione Marketing S P A Dispositivo per l'esecuzione di trattamenti estetici.
DE202006005347U1 (de) 2006-04-03 2007-08-02 Efbe Elektrogeräte GmbH Infrarotleuchte
US20070239147A1 (en) 2006-04-07 2007-10-11 The General Hospital Corporation Method, system and apparatus for dermatological treatment and fractional skin resurfacing
US20090112192A1 (en) 2006-04-18 2009-04-30 Daniel Barolet Method for the Treatment of Skin Tissues
US20090247932A1 (en) 2008-04-01 2009-10-01 Daniel Barolet Method for the treatment of skin tissues
GB0608315D0 (en) 2006-04-27 2006-06-07 Univ St Andrews Light emitting device for use in therapeutic and/or cosmetic treatment
WO2007126339A1 (fr) 2006-05-02 2007-11-08 Hudoley, Vladimir Nikolaevich Appareil physiothérapeutique pour photothérapie et chromatothérapie
JP2007307224A (ja) 2006-05-19 2007-11-29 Ushio Inc 光線治療装置
US8585707B2 (en) 2006-06-07 2013-11-19 Gary S. Rogers Continuous low irradiance photodynamic therapy method
US8246611B2 (en) 2006-06-14 2012-08-21 Candela Corporation Treatment of skin by spatial modulation of thermal heating
JP5010327B2 (ja) 2006-06-26 2012-08-29 パナソニック株式会社 毛成長調節装置
WO2008002625A2 (fr) 2006-06-27 2008-01-03 Palomar Medical Technologies, Inc. Dispositif PHOTOCOSMétique manuel
KR101318968B1 (ko) 2006-06-28 2013-10-17 서울반도체 주식회사 발광 다이오드를 이용한 인공태양광 시스템
EP1878466A1 (fr) 2006-07-10 2008-01-16 WinStone Technology Corp. Appareil de traitement esthétique avec lumière infrarouge et vibration
WO2008008971A1 (fr) 2006-07-13 2008-01-17 Candela Corporation Dispositif manuel, compact pour le traitement de l'acné à domicile
GB2443470A (en) 2006-07-24 2008-05-07 En Ltd Intense pulsed light device with bulb and cooling circuit in removeable cartridge
US20080031924A1 (en) 2006-08-02 2008-02-07 Gilson Darcy J Therapeutic device for delivering controlled air stream flow and/or photodynamic light therapy
US20100010593A1 (en) 2006-08-07 2010-01-14 Koninklijke Philips Electronics N.V. System of plaster and radiation device
US20080045933A1 (en) 2006-08-15 2008-02-21 Paul Perl Multi-broadband pulse emitter and a method for applying an effective dermal treatment
US20080058905A1 (en) 2006-09-01 2008-03-06 Wagner Darrell O Method and apparatus utilizing light as therapy for fungal infection
US20080065175A1 (en) 2006-09-09 2008-03-13 Redmond Russell J Therapeutic radiation device
US20080082148A1 (en) 2006-09-13 2008-04-03 Bernstein Eric F Laser treatment for skin tightening
US20080082149A1 (en) 2006-09-13 2008-04-03 Bernstein Eric F Laser treatment of pigmented lesions on the skin
US7850720B2 (en) 2006-09-23 2010-12-14 Ron Shefi Method and apparatus for applying light therapy
ITBO20060735A1 (it) 2006-10-24 2008-04-25 Rodolfo Pomar Calotta per il trattamento della pelle e del derma.
US20080103560A1 (en) 2006-10-26 2008-05-01 Lumiport, Llc Ultraviolet indicator light therapy device
US20080106896A1 (en) 2006-11-03 2008-05-08 Biboting International Co., Ltd. Illumination device for coupling with cup structure
EP1920798A1 (fr) 2006-11-08 2008-05-14 Roewer, Norbert, Univ.-Prof. Dr. med. Dispositif d'irradiation infrarouge pour l'irradiation de la peau humaine
US20100060195A1 (en) 2006-12-08 2010-03-11 Masanori Tsuboi Light source and light irradiating device
EP1935452A1 (fr) 2006-12-19 2008-06-25 Koninklijke Philips Electronics N.V. Dispostif électrochromique et dispositif pour le traitement photodynamique utilisant un tel dispositf électrochromique
US20100004719A1 (en) 2006-12-25 2010-01-07 Chosei Hamada Optical hair growth modulation device
US20100152645A1 (en) 2007-01-09 2010-06-17 Masahiro Ogasawara Facial Hair-Growth Device and Facial Hair-Growth System
US8206426B2 (en) 2007-01-17 2012-06-26 Lerner Medical Devices, Inc. Light source and fiber optic brush for light delivery
US20080172114A1 (en) 2007-01-17 2008-07-17 Lerner Medical Devices, Inc. Phototherapy handpiece
US20080176206A1 (en) 2007-01-18 2008-07-24 Toshiharu Shinoka Cardiovascular tissue culture substrate
US20080177255A1 (en) 2007-01-22 2008-07-24 R3 Connector Systems Therapeutic coiffuring instrument
US7815630B2 (en) 2007-01-25 2010-10-19 Biolase Technology, Inc. Target-close electromagnetic energy emitting device
US20100100159A1 (en) 2007-01-25 2010-04-22 Chosei Hamada Hair growth modulation device
WO2008095176A1 (fr) 2007-02-01 2008-08-07 Candela Corporation Mélange de longueur d'onde de faisceau lumineux pour diverses maladies dermatologiques
US8961579B2 (en) 2007-02-02 2015-02-24 Medtek Lighting Corporation Portable phototherapy device
EP2115832A4 (fr) 2007-02-06 2012-01-04 Kim Tae Gyu Ensemble diode laser photochimique et feuille photochimique comportant celui-ci
WO2008103922A2 (fr) 2007-02-23 2008-08-28 Reliant Technologies, Inc. Procédé et dispositif pour renforcer des tissus en utilisant un rayonnement électromagnétique
WO2008106576A1 (fr) 2007-02-28 2008-09-04 Keraderm Llc Traitement par photothérapie et dispositif pour améliorer l'aspect des ongles et de la peau
US20080234669A1 (en) 2007-03-19 2008-09-25 Kauvar Arielle N B Method and device for treating skin by superficial coagulation
FR2913888B1 (fr) 2007-03-21 2010-01-01 Jean Pierre Breda Procede et dispositif d'irradiation par rayonnement d'energie photonique modulee
JP2008246144A (ja) 2007-03-30 2008-10-16 Matsushita Electric Works Ltd 毛成長調節方法及びその装置
US8968221B2 (en) 2007-04-17 2015-03-03 Bwt Property, Inc. Apparatus and methods for phototherapy
WO2008131343A1 (fr) 2007-04-19 2008-10-30 Mergenet Medical, Inc. Contrôle temporel en photothérapie
US20080262576A1 (en) 2007-04-20 2008-10-23 Alan Austin Creamer Method, system, and apparatus for somatic treatment
US20080269848A1 (en) 2007-04-24 2008-10-30 Conopco, Inc. D/B/A Unilever Scalp treatment device
US20080269844A1 (en) 2007-04-30 2008-10-30 Logslett Kimberly D Reflective Crib Liner
US20080275533A1 (en) 2007-05-04 2008-11-06 Powell Steven D Display apparatus for providing information and therapeutic light
ES2432179T3 (es) 2007-05-04 2013-12-02 Galderma Research & Development Uso de un derivado del ácido naftoico en combinación con luz roja y/o azul para el tratamiento del acné vulgar
US20080281307A1 (en) 2007-05-09 2008-11-13 Nadine Donahue Therapeutic device incorporating light and cold therapy modalities
US7951138B2 (en) 2007-05-23 2011-05-31 Reliant Technologies, Llc Pivoting roller tip for dermatological treatment apparatus
EP2152365A2 (fr) 2007-05-25 2010-02-17 Koninklijke Philips Electronics N.V. Système d'éclairage pour créer un effet biologique
EP2164568B1 (fr) 2007-05-31 2016-02-24 Koninklijke Philips N.V. Système pour fournir un éclairage et des stimuli physiologiques
WO2008146255A2 (fr) 2007-06-01 2008-12-04 Gabriele Giulini Dispositif portable pour l'émission d'une lumière de couleur bleue
US8187256B2 (en) 2007-06-15 2012-05-29 Alexander J Smits Tattoo removal and other dermatological treatments using multi-photon processing
US8636727B2 (en) 2007-06-29 2014-01-28 Alplight Portable irradiating arrangement
US20090012586A1 (en) 2007-07-05 2009-01-08 Lawrence Eliezer Kepecs Portable wearable cold laser hair growth stimulator and skin treatment system
JP2009028267A (ja) 2007-07-26 2009-02-12 Panasonic Electric Works Co Ltd 光照射美容器具
ATE489019T1 (de) 2007-07-31 2010-12-15 Wella Ag Infrarotstrahlungsvorrichtung
JP2009034239A (ja) 2007-07-31 2009-02-19 Panasonic Electric Works Co Ltd 発毛調節光照射装置
EP2175792A4 (fr) 2007-08-10 2011-07-06 Eleme Medical Inc Dispositif de traitement cutané ou corporel multimodule et procédé d'utilisation
CA2696857A1 (fr) 2007-08-20 2009-02-26 Universite Laval Appareil a lumiere artificielle et utilisation pour influencer l'etat d'un sujet
US20090082836A1 (en) 2007-09-20 2009-03-26 Daniel Schell Methods of applying phototherapy
US9079022B2 (en) 2007-09-27 2015-07-14 Led Intellectual Properties, Llc LED based phototherapy device for photo-rejuvenation of cells
EP2044974A1 (fr) 2007-10-03 2009-04-08 Aracaria B.V. Dispositif de thérapie par lumière de diode électroluminescente (DEL)
EP2044973A1 (fr) 2007-10-03 2009-04-08 Aracaria B.V. Dispositif de thérapie par lumière de diode électroluminescente (DEL)
US20090105791A1 (en) 2007-10-23 2009-04-23 Mcginnis William J Light emitting medical garment device, kit and method of using
US7955366B2 (en) 2007-10-26 2011-06-07 Kai-Shu Sung Biostimulative illumination apparatus
GB0721374D0 (en) 2007-10-31 2007-12-12 Univ Strathclyde Optical device for the environmental control of pathogenic bacteria
DE102007052108A1 (de) 2007-10-31 2009-05-14 Jk-Holding Gmbh Bestrahlungsgerät mit Einrichtungen zur Vermeidung schädlicher Strahlung
US20090143842A1 (en) 2007-11-02 2009-06-04 Cumbie William E Phototherapy Treatment and Device for Infections, Diseases, and Disorders
US20090177190A1 (en) 2007-11-16 2009-07-09 Seung Yoon Lee Lowering skin melanin appearance with red light radiation and red light radiation kit therefor
AU2007361011A1 (en) 2007-11-16 2009-05-22 Seung Yoon Lee Lowering skin melanin appearance with red light radiation and red light radiation kit therefor
US20090177253A1 (en) 2008-01-08 2009-07-09 Oregon Aesthetic Technologies Skin therapy system
US20100331929A1 (en) 2008-02-28 2010-12-30 Koninklijke Philips Electronics N.V. Apparatus for spreading light from multiple sources to eliminate visible boundaries therebetween, light therapy devices including such apparatus, and methods
WO2009113986A1 (fr) 2008-03-11 2009-09-17 Shaser, Inc. Perfectionnement de systèmes de rayonnement optique utilisés dans des traitements dermatologiques
US8083696B2 (en) 2008-03-14 2011-12-27 Headwaters R+D Inc Light and massage multi-therapy hairbrush
EP2291224A2 (fr) 2008-03-18 2011-03-09 PhotoThera, Inc. Procédé et appareil permettant l irradiation d une surface avec une lumière à onde continue ou pulsée
JP5192873B2 (ja) 2008-03-28 2013-05-08 パナソニック株式会社 発毛調節光照射装置
KR101199905B1 (ko) 2008-03-31 2012-11-09 파나소닉 주식회사 모발 성장 장치 및 모발 성장 방법
WO2009121158A2 (fr) 2008-04-01 2009-10-08 Universidade Federal De Minas Gerais - Ufmg Dispositif photobiomodulateur pour la prévention et le traitement de traumatismes mammaires et de lésions non infectieuses des mamelles
EP2106780B1 (fr) 2008-04-03 2016-03-09 Rodolfo Pomar Procédé de traitement du cuir chevelu pour ralentir ou empêcher la chute des cheveux et kit pour effectuer le procédé
EP2288410A1 (fr) 2008-04-10 2011-03-02 Koninklijke Philips Electronics N.V. Système d'éclairage de corps à l'aide d'une lumière bleue
ITBG20080024A1 (it) 2008-04-15 2009-10-16 Dermotricos Srl Dispositivo per l'irraggiamento del cuoio capelluto con sorgenti luminose.
US8452402B2 (en) 2008-04-23 2013-05-28 Medtronic, Inc. Optical sensing device for use in a medical device
US20090270946A1 (en) 2008-04-25 2009-10-29 Paul Spivak Therapeutic Light System
WO2009132585A1 (fr) 2008-04-30 2009-11-05 Yolare Dermaceuticals, Llc. Nouvelle crème anti-âge, dispositif cosmétique et sa crème
US20090281048A1 (en) 2008-05-07 2009-11-12 Pitcher Stephen N Method and System for Inducing Anti-aging in Skin

Patent Citations (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6171332B1 (en) * 1992-10-23 2001-01-09 Photo Therapeutics Limited Light source
US5837224A (en) * 1996-01-19 1998-11-17 The Regents Of The University Of Michigan Method of inhibiting photoaging of skin
US6630516B2 (en) * 1997-02-25 2003-10-07 The Regents Of The University Of Michigan Methods and compositions for preventing and treating chronological aging in human skin
US6130254A (en) * 1997-06-04 2000-10-10 Regents Of The University Of Michigan Methods for inhibiting photoaging of skin
US6398753B2 (en) * 1998-04-03 2002-06-04 Mcdaniel David H. Ultrasound enhancement of percutaneous drug absorption
US6443978B1 (en) * 1998-04-10 2002-09-03 Board Of Trustees Of The University Of Arkansas Photomatrix device
US6030374A (en) * 1998-05-29 2000-02-29 Mcdaniel; David H. Ultrasound enhancement of percutaneous drug absorption
US6676655B2 (en) * 1998-11-30 2004-01-13 Light Bioscience L.L.C. Low intensity light therapy for the manipulation of fibroblast, and fibroblast-derived mammalian cells and collagen
US6629971B2 (en) * 1998-11-30 2003-10-07 Mcdaniel David Process for stimulating hair growth
US6887260B1 (en) * 1998-11-30 2005-05-03 Light Bioscience, Llc Method and apparatus for acne treatment
US6267779B1 (en) * 1999-03-29 2001-07-31 Medelaser, Llc Method and apparatus for therapeutic laser treatment
US6663659B2 (en) * 2000-01-13 2003-12-16 Mcdaniel David H. Method and apparatus for the photomodulation of living cells
US6645230B2 (en) * 2000-03-23 2003-11-11 Photo Therapeutics Ltd. Therapeutic light source and method
US7147863B2 (en) * 2000-07-06 2006-12-12 Regents Of The University Of Michigan UVA (> 360-400) and UVB (300-325) specific sunscreens
US6746444B2 (en) * 2000-12-18 2004-06-08 Douglas J. Key Method of amplifying a beneficial selective skin response to light energy
US6835306B2 (en) * 2001-07-06 2004-12-28 Spx Corporation Return-side filter for use in a vehicle transmission
US7354432B2 (en) * 2003-01-17 2008-04-08 Mcw Research Foundation, Inc. Red to near-infrared photobiomodulation treatment of the visual system in visual system disease or injury

Cited By (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030009205A1 (en) * 1997-08-25 2003-01-09 Biel Merrill A. Treatment device for topical photodynamic therapy and method of using same
US7070611B2 (en) * 1997-08-25 2006-07-04 Advanced Photodynamic Technologies, Inc. Treatment device for topical photodynamic therapy and method of using same
US20060167532A1 (en) * 2005-01-26 2006-07-27 Parker Jeffery R Phototherapy treatment devices for applying area lighting to a wound
US7686839B2 (en) * 2005-01-26 2010-03-30 Lumitex, Inc. Phototherapy treatment devices for applying area lighting to a wound
US20160206897A1 (en) * 2005-04-14 2016-07-21 Photospectra Health Sciences, Inc. Ophthalmic phototherapy device and associated treatment method
US9782604B2 (en) * 2005-04-14 2017-10-10 Photospectra Health Sciences, Inc. Ophthalmic phototherapy device and associated treatment method
US9814903B2 (en) * 2005-04-14 2017-11-14 Photospectra Health Services, Inc. Ophthalmic phototherapy system and associated method
US9974971B2 (en) * 2005-04-14 2018-05-22 Photospectra Health Sciences, Inc Ophthalmic phototherapy method
US10252078B2 (en) 2005-04-14 2019-04-09 Photospectra Health Sciences, Inc. Ophthalmic phototherapy method
US20080033515A1 (en) * 2005-07-20 2008-02-07 Kurtz Andrew F Device for optically stimulating collagen formation in tissue
US20080033514A1 (en) * 2005-07-20 2008-02-07 Kurtz Andrew F Device for optically stimulating collagen formation in tissue
US20070021807A1 (en) * 2005-07-20 2007-01-25 Eastman Kodak Company Device for optically stimulating collagen formation in tissue
USD585997S1 (en) 2006-10-13 2009-02-03 Light Dimensions, Inc. Light-based dermal enhancing apparatus
US20110046538A1 (en) * 2008-02-06 2011-02-24 L'oreal Combination of a light ray with a cytochrome c oxidase substrate particularly for improving the appearance of the skin and/or hair
US9827311B2 (en) 2008-02-06 2017-11-28 L'oreal Combination of a light ray with a cytochrome C oxidase substrate particularly for improving the appearance of the skin and/or hair
US9119798B2 (en) 2008-02-06 2015-09-01 L'oreal Combination of a light ray with a cytochrome C oxidase substrate particularly for improving the appearance of the skin and/or hair
US20100102252A1 (en) * 2008-10-27 2010-04-29 Nicholas Harmon Hand held sterilization devices
US7834335B2 (en) 2008-10-27 2010-11-16 Verilux, Inc. Hand held sterilization devices
US20100104471A1 (en) * 2008-10-27 2010-04-29 Nicholas Harmon Mobile disinfectant device and methods
US8105532B2 (en) 2008-10-27 2012-01-31 Verilux, Inc. Mobile disinfectant device and methods
US8226887B2 (en) 2008-10-27 2012-07-24 Verilux, Inc. Mobile disinfectant device and methods
US20100121419A1 (en) * 2008-11-13 2010-05-13 Ryan Douglas Control of light sources for light therapies
US8784408B2 (en) 2010-02-05 2014-07-22 M. Maitland DeLand LED treatment of dermatologic toxicities associated with vascular endothelial growth factor inhibitors
US20110196351A1 (en) * 2010-02-05 2011-08-11 Deland Maitland M LED Treatment of Dermatologic Toxicities Associated with Multikinase Inhibitors
US20110196353A1 (en) * 2010-02-05 2011-08-11 Deland Maitland M LED Treatment of Dermatologic Toxicities Associated with Epidermal Growth Factor Receptor Inhibitors
US8795263B2 (en) 2010-02-05 2014-08-05 M. Maitland DeLand LED treatment of dermatologic toxicities associated with multikinase inhibitors
US8496008B2 (en) 2010-03-31 2013-07-30 Oncologics, Inc. Oral device for radiotherapy
US8430102B2 (en) 2010-03-31 2013-04-30 Oncologics, Inc. Oral device for radiotherapy
US20130324909A1 (en) * 2011-02-14 2013-12-05 Merck Patent Gmbh Device and method for treatment of cells and cell tissue
US9492681B2 (en) * 2011-02-14 2016-11-15 Merck Patent Gmbh Device and method for treatment of cells and cell tissue
US9278232B2 (en) 2011-03-17 2016-03-08 Jk-Holding Gmbh Device for irradiating actinic radiation of different wavelengths
US8330121B2 (en) 2011-05-03 2012-12-11 Verilux, Inc. Dynamic display and control of UV source for sanitization in mobile devices
US10881550B2 (en) 2014-09-09 2021-01-05 LumiThera, Inc. Multi-wavelength phototherapy systems and methods for the treatment of damaged or diseased tissue
US12336937B2 (en) 2014-09-09 2025-06-24 LumiThera, Inc. Multi-wavelength phototherapy devices, systems, and methods for the non-invasive treatment of damaged or diseased tissue
US10596037B2 (en) 2014-09-09 2020-03-24 LumiThera, Inc. Devices and methods for non-invasive multi-wavelength photobiomodulation for ocular treatments
US10219944B2 (en) 2014-09-09 2019-03-05 LumiThera, Inc. Devices and methods for non-invasive multi-wavelength photobiomodulation for ocular treatments
US20160220804A1 (en) * 2015-02-03 2016-08-04 L'oreal Apparatus and method for skin treatment using continuous light
US10039600B2 (en) 2015-02-03 2018-08-07 L'oreal Apparatus and method for skin treatment using pulsed light
US9687643B2 (en) * 2015-02-03 2017-06-27 L'oreal Apparatus and method for skin treatment using continuous light
US20160346565A1 (en) * 2015-05-29 2016-12-01 Nathaniel L.R. Rhodes Methods and apparatus to deliver therapeutic non-ultraviolet electromagnetic radiation to a body surface

Also Published As

Publication number Publication date
WO2005011606A3 (fr) 2006-12-28
EP1648385B1 (fr) 2016-05-04
JP2007518452A (ja) 2007-07-12
CN101247768A (zh) 2008-08-20
EP1648385A4 (fr) 2009-02-04
JP4739202B2 (ja) 2011-08-03
US9144690B2 (en) 2015-09-29
ES2572976T3 (es) 2016-06-03
KR20060060670A (ko) 2006-06-05
US20100137950A1 (en) 2010-06-03
EP1648385A2 (fr) 2006-04-26
KR101160343B1 (ko) 2012-06-26
WO2005011606A2 (fr) 2005-02-10
IL173123A0 (en) 2006-06-11
CA2533129A1 (fr) 2005-02-10
US20150328479A1 (en) 2015-11-19

Similar Documents

Publication Publication Date Title
EP1648385B1 (fr) Systeme et methode de traitement photodynamique de la peau
US8651111B2 (en) Photomodulation methods and devices for regulating cell proliferation and gene expression
Sorbellini et al. Photodynamic and photobiological effects of light-emitting diode (LED) therapy in dermatological disease: an update
Weiss et al. Clinical trial of a novel non‐thermal LED array for reversal of photoaging: clinical, histologic, and surface profilometric results
Spencer et al. Indoor tanning: risks, benefits, and future trends
US9737728B2 (en) Method for the treatment of mammalian skin tissues via pulse irradiation in the presence of a photoactive compound
US20090317911A1 (en) System and method for photodynamic cell therapy
Dierickx et al. Visible light treatment of photoaging
Jung et al. Prospective randomized controlled clinical and histopathological study of acne vulgaris treated with dual mode of quasi-long pulse and Q-switched 1064-nm Nd: YAG laser assisted with a topically applied carbon suspension
Kohl et al. Aesthetic effects of topical photodynamic therapy
KR20150032994A (ko) 피부개선 및 발모용 광 요법 장치
Wanitphakdeedecha et al. Local and systemic effects of low-level light therapy with light-emitting diodes to improve erythema after fractional ablative skin resurfacing: a controlled study
DE602004008661T2 (de) Gerät zur beleuchtung einer zone von säugetierhaut
Railan et al. Laser treatment of acne, psoriasis, leukoderma, and scars
US20100081185A1 (en) System and method for photodynamic cell therapy
US20060173512A1 (en) Method for protecting mammalian skin against upcoming photodamage
Mezzana “Multi Light and Drugs”: a new technique to treat face photoaging: Comparative study with photorejuvenation
HK1092346A (en) Photomodulation methods and devices for regulating cell proliferation and gene expression
Edge et al. Biophotonic Therapy Induced Photobiomodulation
Prager-Zimny et al. The Impact of LED Therapy on Skin: The Review
Menezes et al. Photobiomodulation Using Amber Led and Infrared Laser to Controlling the Pigmentation and Flaccidity from Skin
Sawhney et al. Low-Level Laser (Light) Therapy for Cosmetics and Dermatology
McDaniel et al. LED photomodulation for reversal of photoaging and reduction of inflammation
Calderhead 27 Skin Aging Clock and Its Resetting by Light-Emitting Diode Low-Level Light Therapy
Demidova et al. Wound healing stimulation in mice by low-level light

Legal Events

Date Code Title Description
AS Assignment

Owner name: LIGHT BIOSCIENCE, LLC, VIRGINIA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:MCDANIEL, DAVID H.;REEL/FRAME:016342/0869

Effective date: 20050221

AS Assignment

Owner name: GENTLEWAVES LLC, NORTH CAROLINA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:LIGHT BIOSCIENCE LLC;REEL/FRAME:022928/0329

Effective date: 20090629

Owner name: GENTLEWAVES LLC,NORTH CAROLINA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:LIGHT BIOSCIENCE LLC;REEL/FRAME:022928/0329

Effective date: 20090629

STCB Information on status: application discontinuation

Free format text: EXPRESSLY ABANDONED -- DURING EXAMINATION

AS Assignment

Owner name: GENTLEWAVES LIMITED, BAHAMAS

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:GENTLE WAVES LLC;REEL/FRAME:023660/0950

Effective date: 20090923

Owner name: GENTLEWAVES LIMITED,BAHAMAS

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:GENTLE WAVES LLC;REEL/FRAME:023660/0950

Effective date: 20090923

AS Assignment

Owner name: GENTLE WAVES LLC, NORTH CAROLINA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:GENTLEWAVES LIMITED;REEL/FRAME:023668/0411

Effective date: 20091217

Owner name: GENTLE WAVES LLC,NORTH CAROLINA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:GENTLEWAVES LIMITED;REEL/FRAME:023668/0411

Effective date: 20091217